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Transition from tissue engineering research to tissue engineering 
product is challenging. This is partly due to the fact that there are still significant 
gaps in the fundamental knowledge that make the transition from applied 
research to product development in tissue engineering difficult if not impossible. 
One way to overcome such gap is to avoid or minimize the changes needed from 
tissue engineering research to tissue engineering product development. This can 
be done by initiating the tissue engineering research with a very specific aim in 
mind and translating the target’s requirements systematically into research 
specifications. In this work, we developed a hepatotoxicity testing platform that 
gears towards industry-scale early stage drug screening applications. We 
adapted and applied ideas from product development to identify the important 
requirements to meet the goal. By taking account of user requirements and 
guidelines in the early stage of research, we can minimize the changes needed 
further downstream of the tissue engineering development.  
We identified robustness and scalability as two essential criteria for 
industrial cell-based drug screening platforms. We designed a robust 
hepatocytes-based drug screening platform by replacing collagen gel with 
galactosylated microfabricated silicon nitride membrane in the sandwich culture, 
and having perfusion culture to maintain stable hepatocytes functions over 2 
weeks. Scalability was achieved by conforming to standard culture plate 
dimension that allows incorporation of robotic liquid handler for large scale 
drug testing. We have demonstrated that the platform is robust with high mass 
transfer efficiency and provide uniform nutrient access that support uniform cell 
viability throughout the bioreactor. We also demonstrated high throughput 
xiv 
 
capability by conducting IC50 test using robotic liquid handler. Coupled with 
our previous results of high hepatocytes functionality, higher sensitivity and 
lower variability in drug testing results over different days, we have shown 
promising design for a robust and high throughput drug testing platform.  
We then proceeded to fine-tune the materials and culture configurations 
used in the platform. To preserve spheroids morphology in sandwich-
constrained configurations, we introduced a soft polyethylene glycol hydrogel 
layer to prevent the hepatocytes spheroids from spreading. We found that the 
hepatocytes cultured in the improved sandwich-constrained spheroids culture 
show higher albumin synthesis, improved drug transporter RNA expression, 
and higher CYP1A2 and CYP3A2 basal and induced activities compared to the 
original configurations.  
 In order to improve the robustness of the system, we replaced the brittle 
silicon nitride porous membrane with parylene C porous membrane, which is 
more flexible and elastic, to improve the robustness of the membrane. The 
bottom polyacrylic acid/galactose surface prepared by random UV-induced 
crosslinking was replaced by direct crosslinking of polyethylene 
glycol/galactose with fixed molecular weight. The resulting surface was 
smoother and more uniform where hepatocytes were able to form spheroids 
with higher efficiency and uniformity. A thin layer of polyethylene 
glycol/galactose was introduced to the top parylene C membrane maintain its 
spheroids morphology despite being constrained between 2 layers of 
membranes. As a result, we created a sandwich-constrained hepatocytes 
spheroids culture that is subjectable to perfusion culture flow. We found that 
the synergistic effect of perfusion flow and spheroids culture configuration 
xv 
 
significantly enhanced hepatocytes function such as improved urea secretion, 
CYP1A2 and CYP3A2 activities, and apical transporter MRP2 distribution. The 
design is transferable between static well plate and perfusion flow, thereby 
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Drug induced liver injury is one of the main causes for drug attrition and 
restricted drug used during drug development [2, 3]. As the cost to develop a 
drug is rising exponentially along with the phase of development, eventually 
reaching US$800 million per drug [4], there is an urgent need for 
pharmaceutical industry to identify potential toxicity profile in the earlier 
development stage. On the other hand, combinatorial chemistry as well as 
molecular biology and genomics understanding have led to a rapid growth of 
novel compounds [5]. As a result, in vitro drug metabolism testing platform are 
gaining increasing importance compared to its animal model counterpart in the 
early stage drug screening given its high throughput testing capacity.   
The usability and predictability of an in vitro drug metabolism and 
hepatotoxicity testing platform is highly depending on the quality of the testing 
model. Many models, ranging from sub-cellular p450 microsomes [6] , to cell 
lines[7], to perfused liver slices [8], have been investigated for drug-induced 
hepatotoxicity screening. Among them, isolated primary hepatocytes appear as 
the most promising model as they strike a balance between throughput and 
maintaining basic cell architecture and functions [9]. Isolated primary 
hepatocytes rapidly lose their differentiated functions when seeded directly on 
conventional culture plate, thereby limiting their drug testing period to less than 
two days[10]. To prolong primary hepatocytes functionality, numerous culture 
configurations have been developed. They can be broadly divided into three 
categories: sandwich culture, spheroids/tissue-like culture and perfusion culture. 
Sandwich culture, where isolated hepatocytes are sandwiched between two 
layers of extracellular matrices such as collagen [11, 12], has shown to be able 
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to re-establish the differentiated hepatocytes functions such as urea and albumin 
secretion [12], biotransformation enzyme functions [13], polarity and 
transporter activities[14]; making it the model recommended by the US Food 
and Drug Administration for in vitro drug metabolism and toxicity studies [15]. 
Spheroids cultures are multicellular 3D aggregates in suspension or substrates 
that promote tight cell-cell interactions. Hepatocytes spheroids maintain high 
levels of liver-specific functions such as albumin production, urea synthesis, 
cytochrome p450, and glucuronidation activity [16-18]. Their structures are 
highly similar as those found in native liver tissue with established structural 
polarity and functional bile canaliculi[19].   
In contrast to the static flow used in sandwich and spheroids cultures, 
perfusion culture allows continuous replacement of media that mimic blood 
circulation mechanism in vivo. It has been shown that perfusion culture further 
maintains the hepatocytes biotransformation functions [20] due to improved 
oxygen and nutrients delivery as well as efficient waste removal[21, 22].  In fact, 
hepatocytes cultured under perfusion condition demonstrate consistent drug 
response at different culture time points over a long culture period, allowing 
drug testing to be conducted using same pool of cells over a period of time 
[23].Ideally, perfusion culture can combined with either sandwich or 
spheroids/tissue-like culture to provide the best culture environment for 
hepatocytes. However, many of the existing hepatocyte perfusion culture 
platforms do not conform to the standard cell culture plate dimensions, making 
them difficult to be adopted by pharmacologist for drug screening. Most of them 
are also limited with throughput and parallel processing capability for drug 
testing assay [24], which limits their used in industry. Here we plan to develop 
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a high throughput and robust drug screening platform using perfusion sandwich 




2 Background and Significance 
2.1 Liver Tissue Engineering for Early Stage Drug Testing  
2.1.1 The pharmaceutical drug development landscape 
According to a study published by DiMasi et al, the cost of discovering 
and developing a drug was in the order of US $804 million in 2001[4], where 
the current estimates are closer to ~US $900 million [25]. On the other hand, 
only ~10% of the drugs that entered Phase I trial were successfully marketed 
[25], with 62% of all compounds that enter Phase II trials and 45% of all 
compounds that enter Phase III trials — where significant amounts of the costs 
of discovering and developing a drug would have been incurred — undergo 
attrition. Even at the registration stage – where all the trials and the 
documentation for submission have been completed, thereby incurring the full 
discovery and development costs and the opportunity costs, which, on average, 
could be as much as 12 years 10 months – the failure rate of compounds is 23%. 
The expensive failure of drugs candidate in the late stage of the drug 
development pipeline has prompted the biggest pharmaceuticals companies to 
be interested in early stage screening technologies that offer “fail early, fail 
often” approach. 
2.1.2 The importance of liver model during drug development   
The liver is important for drug development because it directly affects 2 
main criteria of a drug: the bioavailability (which also affects the drug efficacy) 
and toxicity. These are also the two main challenges encounter by drug 
development today [26]. Bioavailability and toxicity can be related at least in 
part to hepatic drug metabolism. Thus, having a liver model with proper 
metabolic reaction will have 2 main advantages: First, it provides early 
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understanding of drug metabolism pathway. The liver is the main metabolism 
organ of the human body. Drugs, especially when admitted orally, will be 
subjected to chemical modification in the liver. Such biotransformation will 
alternate the chemical structure of the compound, which will distinctly alter and 
determine the drug’s disposition in the body, inter-individual pharmacokinetics, 
and the clinical efficiency and toxicity of the drugs [27]. Having an early 
understanding of how the drugs are metabolized can lead to better choice of 
drug leads that would more likely to give positive effects [28]. Second, it serves 
to identify drug-induced liver injury early. Drug-induced liver injury is the 
leading cause of restricted drug use, post-marketing drug withdrawal, and 
attrition due to toxicity during drug development [2]. To be able to detect 
toxicity event in the early stage of development allows one to terminate the 
project before large amount of investment was involved. 
2.2 Hepatic Drug Metabolism 
The hepatic drug metabolism occurs in the hepatocytes, which 
represents about 80% of the total volume and 60% of the total cells found in 
liver [29]. The hepatocytes machinery involved in the biotransformation of 
drugs can be briefly divided into 4 groups: (1) Phase 1 enzymes, (2) Phase 2 
enzymes, (3) Transporter and (4) Xenosensors.  
2.2.1 Phase I enzymes 
The phase I enzymes catalyze oxidative and reductive reaction. Among 
them, the cytochrome p450s family (CYPs), is the major player in the oxidative 
metabolism of xenobiotics and endogenous compounds [30] and is responsible 
for the metabolism of most drugs [31]. The CYPs is a superfamily of 
microsomal enzymes with more than 12 gene families and 22 subfamilies, in 
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mammals [32]. In human, 70% of the liver p450 are CYP1A2, 2B6, 2C, 2D6, 
2E1 and 3A. The CYP1, CYP2 and CYP3 are the 3 main gene families which 
are responsible for drug metabolism [33]. Given the big spectrum of p450, only 
enzymes that exists substantially in the liver or heavily involved in drug 
metabolism are recommended for testing. A list of such enzymes adapted from 
Hewitt et al. [34] and Wienkers [35] was given in Table 1.  
Table 1. Relative Abundance of Human CYP Enzymes and Their Contribution 




(isoforms in rat) 
Content in liver 
(% total CYP) 
% of drugs metabolized 
by enzyme 
CYP1A2 CYP1A2 13 6-9 
CYP2B6 CYP2B1 5 25 
CYP2C9 CYP2C6, 2C11 12 11-16 
CYP2C19 CYP2C6, 2C11 0.2 12 
CYP2D6 CYP2D1/2 1.5 12-30 
CYP2E1 CYP2E1 7 5 
CYP3A4/5 CYP3A1/2 30 46-52 
 
2.2.2 Phase II enzyme 
Phase II enzymes are responsible for conjugation reactions such as 
glucuronidation, sulfation, methylation, acetylation, acetylation, glutathione 
and amino acid conjugation. They are mostly transferases, eg. UDP-
glucuronosyltransferases (UGTs), sulfotransferases (SULTs), N 
acetyltransferasesases (NATs), glutathione S-transferases (GSTs), various 
methyltransferases (mainly thiopurine S-methyl transferase (TPMT) and 
catechol O-methyl transferase (COMT)). Phase II enzymes generally receive 
less attention than p450 because there are lesser drugs that interact with them. 
Nevertheless, three of the phase II enzymes, the UGTs, SULTs and the GSTs 




For a drug to be metabolized by the metabolizing enzyme mentioned 
above, it has to first enter the hepatocytes. Lipophilic molecules may move from 
plasma to hepatic cytosol by simple or facilitated diffusion. However, for 
amphipathic and polar organic compounds, as well as some lipophilic molecules, 
they have to rely on numerous transport proteins to move from sinusoidal 
plasma to hepatic cytosol. On the other hand, the metabolites, which are 
frequently more polar than their parents, also rely on transporters to translocate 
from hepatocytes cytosol to sinusoidal blood or bile canaliculi for excretion. 
Given the role of transporter in controlling the influx and efflux of xenobiotics, 
they are in the delicate position of determining drug or metabolites excretion 
(which affects drug bioavailability) [37, 38] and hepatocytes exposure to drug 
(which affects hepatotoxicity) [39]. As such, although hepatic transporter is a 
relatively new field, it is gaining importance in drug development rapidly [36]. 
Many transporters have been identified in the hepatocytes. The more 
important ones which affect drug absorption, disposition and/or drug-induced 
liver injury include the sodium/taurocholate co-transporting peptide 
(NTCP),organic anion-transporting polypetides,(OATP), organic anion 
transporter (OATs), multidrug resistance proteins (MDR), multidrug resistance 
associated proteins (MRP), bile salt export pump (BSEP), and breast cancer 
resistance protein (BCRP) [40, 41]. The transporters in hepatocytes can be 
briefly divided into two groups depending on their location: the 
basolateral/sinusoidal membrane transporters and the apical/canalicular 
membrane transporters. The correct localization of these transporter proteins at 
the correct side of the membrane (i.e polarity reestablishment) is crucial. 
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However, reestablishing the polarity of the hepatocytes is particularly tricky due 
to its complex polarity formation[42] .  
 
Figure 1. Schematic representation of major hepatocytes transporter involved 
in drug development. Adapted by permission from Macmillan Publishers Ltd: 
[32], Copyright 2014.  
 
2.2.4 Nuclear receptors 
The activities of phase I, phase II metabolizing enzymes and the 
transporters mentioned above are normally present at low basal un-stimulated 
level, but will increase significantly after induction by xenobiotics. Such 
induction is controlled by a series of signaling pathways which involves nuclear 
receptors such as aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR) 
and constitutive androstane receptor (CAR)[41]. This mechanism is evolved in 
the human body in order to facilitate the metabolism and elimination of 
potentially harmful drugs. However, from drug development point of view, such 
mechanism will significantly alter the metabolism, elimination, 
pharmacokinetics, toxicokinetics and drug-drug interactions of many 
therapeutics agents. Therefore, understanding the signaling pathway and 
ensuring the nuclear receptors to be intact in the in vitro model are crucial to 
screen for drug metabolizing pathway and potential drug-induced liver injury 
occurrence [32].   
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2.3 Drug-induced liver injury  
Drug-induced liver injury is a leading cause of acute liver failure and 
post-market drug withdrawal [43]. It accounts for approximately half of the 
acute liver failures [44]. More than 600 current drugs have the potential to cause 
liver injury in man [45]. One of the problems in identifying drug-induced 
hepatotoxicity is that only half of the pharmaceuticals that produced 
hepatotoxicity in human shows some concordant signals in animals safety 
testing [46], rendering animal models insufficient in detecting such event.   
2.3.1 Formation of reactive metabolite during drug metabolism  
Drug metabolism that takes place in the hepatocytes plays a key role in 
drug-induced liver injury. When drugs are metabolized, they are frequently 
converted from relatively nonpolar compound into more polar compound for 
excretion into bile or urine. However, some of these metabolites are chemically 
reactive and able to bind covalently to the cell proteins [47], triggering cell death 
(e.g APAP) or immune-response in the liver (eg dihydralazine). It was reported 
that roughly 2/3 of the drugs that cause idiosyncratic drug-induced 
hepatotoxicity in human form reactive metabolites; 85% of the 27 drugs 
eliciting liver toxicity and were withdrawn from the market or with restricted 
use are known to forms reactive metabolites [48]. These statistics suggest the 
importance of drug metabolism and their reactive end product as a risk factor in 
drug-induced liver injury [41]. 
2.3.2 Phase I and Phase II Enzyme inhibition and induction 
Another factor is CYPs induction. As discussed previously, some of the 
drugs have the potential to increase the expression or the activity of certain 
CYPs. If the target CYPs were involved in reactive metabolite production, such 
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induction will potentiate the formation of toxic metabolite [49]. For example, 
induction of CYP2E1 in human by alcohol increased the formation of N-acetyl-
p-benzoquinoneimine (NAPQI) from acetaminophen.    
2.3.3 Inhibition or induction of transporter 
Lastly, interaction of drugs with hepatocytes transporters can influence 
or cause drug-induced liver injury. For example, inhibition of transporters 
responsible for the efflux of bile salts from hepatocytes is considered as an 
important mechanism that causes cholestasis. These drugs cause liver injury by 
accumulating high level of cytotoxic bile salts within the hepatocytes. 
Alternatively, inhibition of transporters might also cause intracellular 
accumulation of drugs or drugs metabolites that leads to hepatocytes toxicity 
[41].   
2.4 Hepatocytes cell culture model 
Given the importance of liver mentioned above, it is not surprising to 
find that tremendous efforts have been put into developing suitable in vitro liver 
tissue model for the purpose of drug development[50] (Table 2). For some of 
the metabolism studies involving phase I enzymes, considerable success in 
metabolic prediction has been achieved by using liver microsomes. In fact, the 
usage of liver microsomes during the early ADME studies is known to 
contribute towards the significant drop in drug attrition due to ADME from 
1990 to 2000 [51]. However, despite the ease of use, liver microsomes lacks 
phase II transformation enzymes and transporter proteins. This means that they 
might fail to capture conjugation events and drug interactions with transporters. 
On the other hand, in vitro models such as isolated perfused livers or liver tissue 
slices are difficult to use in high throughput applications despite their close 
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imitation to in vivo liver tissue. Standing in the middle of the spectrum are the 
isolated primary hepatocytes, which strike a balance between high throughput 
and intact cellular architecture [52]. However, isolated primary hepatocytes 
rapidly lose their differentiated functions when cultured using standard cell 
culture condition[53]. Therefore numerous culture models have been developed 
to prolong their functions. The more significant ones include sandwich culture 
model, spheroids culture model, and perfusion culture model.   
Table 2. In vitro liver model for drug testing [50, 52] 
In vitro model Advantages Disadvantages 
Subcellular fractions 
(microsomes, cytosol, 
S9 fractions, enzyme 
supersomes)  
 High throughput 
 Maintain Phase I 
metabolic enzyme 
 Lacks Phase II 
metabolic enzyme, 
transporters 
Transgenic cell line  Unlimited supplies 
 Easy to culture 
 Certain enzyme 
functions at high level 
 Poor correlations 
with in vivo enzyme 
profiles 
 Only few enzymes 
are expressed 
Hepatic cell line  Unlimited supplies 
 Easy to culture 
 Absence or low 
expression of phase I 
and phase II enzymes 




 Impure hepatocytes 
differentiation 
 Low efficiency and 
high cost 
Primary hepatocytes  Well characterized 
 Reasonably 
throughputs depends 
on culture models 
used  
 Many cell culture 
model developed to 
prolong viability and 
differentiated 
functions 




 Cell injury during 
isolation 
 Viability < few days 
if not preserved in 
any culture model 
 No single culture 
model can preserve 
all functions 
Liver tissues slices  Intact cytoarchitecture 
 Functional drug 
metabolizing enzyme, 




transporters and bile 
canaliculi 
 Mass transport 
barrier 
 Cellular injury at the 
edge 
Isolated perfused liver  Closest to in vivo 3D 
architecture and 
conditions 
 Bile formation 
 Short viable period 
(2-4 hours) 
 Complex to handle 
and setup 
 Low throughput 
 
2.4.1 Sandwich culture model 
The sandwich culture model [31, 54-56], with hepatocytes cultured in 
between two layers of collagen or matrigel, is one of the more established 
culture configurations and has been recommended by the FDA for various drug 
testing applications [15, 34]. Sandwich culture hepatocytes have shown to 
maintain better hepatocytes morphology, ie. Keeping it in cuboidal shape. It 
also mimics hepatocytes in vivo environments where hepatocytes are 
sandwiched between basement membrane in the space of Disse. More 
importantly, the overlay causes a dramatic reorganization of the cytoskeleton 
and adoption of in vivo-like polarity with exhibition of tight and gap junctions, 
localization of canaliculi transporters on apical membrane, and expression of 
biliary excretion [57-59]. Bile acid is excreted across the apical surface and 
albumin is secreted across the basolateral surface, mimicking the in vivo 
environments [60]. Gene expression analysis shows that liver specific genes 
were upregulated in sandwich-cultured hepatocytes [61] which contributes to 
their higher hepatocytes-specific functions compared to monolayer-cultured 
hepatocytes [12].  
The maintenance of liver specific functions, especially drug 
metabolizing enzymes has made it a good model for various drug testing 
applications such as hepatotoxicity testing [62] and drug induction testing[41]. 
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More importantly, its establishment of functional and extensive bile canalicular 
networks makes it an ideal candidate to evaluate the effect of bile acid transport 
in drug clearance [63] [34]. However, despite the advantages, Hewitt et al 
[41]found that only 30% of the surveyed correspondents use sandwich cultures 
for drug testing related studies. Some finds that batch to batch variation of the 
complex extracellular matrix component complicates their studies [64]. Other 
reports mass transport barrier arising from thick and uncontrollable collagen 
coating [65]. It has been reported that bioavailability of polypeptide drugs was 
compromised by collagen overlay [41]. These drawbacks are issues to be 
considered when using collagen sandwich cultured hepatocytes for drug testing 
purposes.   
2.4.2 Spheroids culture model 
Hepatocytes form aggregates when they are weakly adherent or non-
adherent to the culture substrate. Compared to sandwich culture and traditional 
monolayer culture, hepatocytes spheroids exhibit different cytoarchitecture; 
Actin filaments in hepatocytes tended to concentrate at the cell-cell contact 
region; extracellular matrix components such as laminin, fibronectin and 
collagen were secreted and accumulated [66]; Hepatocytes spheroids exhibits 
changes in cell shape, establishment of tight cell-cell contacts and membrane 
reorganization resulting in a more polarized structures and emergence of bile-
canalicular channels within spheroids [19]. The presence of the 3-dimensional 
cytoarchitecture through the re-establishment of 3D cell-cell contacts, together 
with the secretion of extracellular matrix material within the spheroid, has been 
hypothesized to contribute to better maintenance of differentiated functions than 
in traditional matrix overlay[67] and matrix monolayer culture [68]. Studies 
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have shown the maintenance of the drug metabolizing enzymes in extended 
cultures of spheroids [17] as well as induction of some key enzymes in response 
to prototypical inducers [53]. Global gene expression analysis shows that many 
gene expression of liver specific functions, such as albumin secretion, 
ureagenesis, metabolic enzymes, transcription factors, transporters, are higher 
in spheroids compared to 2D monolayer culture.[69] [68].  
Many different types of culture models and materials have been 
designed for hepatocytes spheroids culture (Table 3). Most of them based on 
the spontaneous assembly of hepatocytes into spheroids formation when seeded 
on non-adhesive or low adhesion surfaces. As a results, many of them face cell 
loss issues [70], which leads to quantification difficulties and variation for 
downstream drug testing. Some of them are not based on conventional well plate 
format or have bulky structures, which makes it difficult to be adapted for drug 
testing. Moreover,  large hepatocytes spheroids is hindered by diffusional limits 
of oxygen, nutrients, and waste into the multicellular structures [71]. The 
presence of necrotic/ hypoxia cells in the center is often detected in spheroids 
that is larger than 150µm in diameter [72]. It is therefore crucial to overcome 
these issues if hepatocytes spheroids are chosen as the model for drug testing.  
 
Table 3. Hepatocytes spheroids culture models 






 No specialized 
modification 
needed 








[69, 73, 74] 
Low adhesion 
modified surface  
 Compatible 
with well plate 
format 
 









with well plate 
format 











 Cell lost [67, 80, 81] 
Polymeric 
scaffold, gel or 
sponge 
 Trap spheroids 
in scaffold 
 Limit size 
growth 




 Impede drug 
access 








2.4.3 Perfusion culture model 
The perfusion culture models differ from previous model in the way that 
media was continuously replaced. Oxygen and nutrients transport, as well as 
waste removal from cellular local environment, was improved [86]. As a result, 
hepatocytes cultured in perfusion bioreactors shows improvements in viability, 
life span and metabolic performance of primary hepatocytes [20]. The Phase I 
and Phase II enzymes also show long term stability in perfusion culture [21]. 
Perfused-cultured hepatocytes respond well to inducer and have shown stable 
induction of p450 up to 7 days [87]. 
However, the improvement of mass transfer from the continuous flow is 
accompanied by concomitant increased in shear stress experienced by 
hepatocytes. In vivo, hepatocytes are shielded by liver sinusoidal epithelial cells, 
which limit their exposure to shear stress. It has been reported that high shear 
stress are detrimental to hepatocytes viability and functions [88-90], therefore 
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it is essential to control the amount of shear expose to hepatocytes in perfusion 
bioreactors.  
On the other hand, a lot of the perfusion bioreactors for hepatocytes 
culture were developed in the context of bioartificial liver assist device, which 
main purpose is to act as an artificial extracorporeal supportive device for 
individual who is suffering from acute liver failure. As a results, many of the 
existing hepatocyte perfusion culture platforms do not conform to the standard 
cell culture plate dimensions. They are also typically limited with throughput 
and parallel processing capability for drug testing assay [24], which limits their 
usability in drug testing context.  
The various types of hepatocytes culture perfusion bioreactors can be 
roughly grouped into 4 different groups: suspension tank perfusion bioreactor, 
scaffold based perfusion bioreactor, well based perfusion bioreactor and 
microfluidic based perfusion bioreactor (Table 4). Among them, suspension 
tank, scaffold based, and flat plate bioreactors were originally developed for 
bioartificial liver assist device, but later adopted for drug testing usage. 
Hepatocytes are cultured in bulk, either in suspension or seeded into 
scaffold/hollow fibers/packed bed, where the system was then subjected to 
perfusion flow. Although hepatocytes differentiated functions can be 
maintained in such bulk perfusion system, it is very difficult to adapt them into 
drug testing process as cells need to be compartmentalized for drug testing 
results comparisons. Some of the scaffold based and flat plate based perfusion 
bioreactors can be scaled down for drug testing purposes. Yet, they do not have 
multiplex and parallel processing capabilities, thus the setups required increases 
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in multitude when large amount of parallel testing are involved, making it 
impractical to be used for drug screening purposes.  
In contrast to the models mentioned above, well-plate based perfusion 
bioreactors and microfluidic devices are geared towards drug testing purposes: 
they generally use less media therefore require less testing compound, are 
compartmentalized, and have parallel processing capabilities. Yet, the 
hepatocytes culture microenvironments is typically sacrificed for the throughput, 
ie. Cells are often directly seeded into the bioreactors without first established 
in spheroids or sandwich configurations. Many of the well plate perfusion 
bioreactors also utilize tangent flow instead of laminar flow in order to constrain 
the fluidic system within the well-plate setup. Both of these designs jeopardize 
hepatocytes differentiated functions. 
Table 4. Perfusion bioreactor for hepacoytes culture 




 Relatively easy 
setup for big 










 Relatively easy 
setup for big 
quantity of cells 
culture 










 Laminar flow 
reduce shear 
 






 Parallel processing 
capabilities  





 High shear from 
tangent flow 








 Requires small 
amount of culture 
media and testing 
materials 
 Parallel processing 
capabilities  
 High surface to 
volume ratio 
 Extensive setup 
requires for each 
experiments 




2.5 Engineering microenvironment for hepatocytes cell culture 
2.5.1 Extracellular matrix manipulation 
Extracellular matrix affects numerous cell behaviour such as cell 
adhesion, cell spreading, migration, and proliferation via specific interactions 
with the cell surface receptors. The control of the physicochemical properties of 
the extracellular matrix is very useful for optimizing the functional maintenance 
of the cells in vitro. Given that hepatocytes are anchorage-dependent cells, 
engineering a suitable extracellular matrix for hepatocytes culture is extremely 
important to maintain their viability and differentiated functions [95, 96]. 
2.5.1.1 Natural extracellular matrix 
The hepatocytes microenvironments in vivo consists of a plethora of 
extracellular matrix proteins such as collagen type I and IV, fibronectin, laminin, 
that provide physical support and ligands-receptors interactions that regulate 
hepatocytes functions and behaviours [97]. Hepatocytes have been routinely 
seeded on surfaces that are coated with these extracellular matrix proteins in 
order to re-establish hepatocytes functions in vitro. Hepatocytes attached well 
on these surfaces, although they displayed a flattened and spread morphology 
and exhibited low liver specific functions. The interactions between hepatocytes 
and extracellular matrix are mediated by cell surface receptors such as integrins. 
For example, integrin α2β1 interacts with collagen ligands which activates Akt 
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and ERK signalling [98]. Most of the extracellular matrix proteins contain 
homologies sequences Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR), 
which interact with several of integrins. As such, these peptides have been 
synthesized and conjugated onto surfaces for hepatocytes culture. Similar to 
hepatocytes cultured on extracellular matrix coated surface, hepatocytes 
cultured on RGD-conjugated surface attached well, but display low hepatic 
functions, indicating dedifferentiation process [99]. On the other hand, when 
hepatocytes cultured in sandwich configurations which overlaid by collagen or 
matrigel, hepatocytes maintain a cuboidal morphology with reestablishment of 
polarity and hepatic functions [59]. This suggests that extracellular matrix 
influences the expression of differentiated functions through organization of 
cytoskeleton [96]. Nevertheless, using natural extracellular matrix protein for 
cell culture is complicated by its batch to batch variation, low reproducibility 
and high cost of production.       
2.5.1.2 Synthetic extracellular matrix 
The interest in synthetic extracellular matrix has been growing given its 
lower cost, higher reproducibility, processability and tunable mechanical 
properties [100]. Many polymers have been developed as scaffolds for 
hepatocytes culture such as polyglycolic acid (PGA) and polylactic acid (PLA), 
polylactic glycolic acid (PLGA), polycaprolactone (PCL), poly-β-
hydroxybutyrate (PHB), polyurethane and polycarbonate, poly(vinyl alcohol) 
gels (PVA), poly(ethylene oxide) (PEO), polyethylene glycol (PEG) and 
biorubber etc [101]. Hepatocytes cultured in these scaffolds exhibit various 
morphology and differentiated functions depending on the mechanical and 
chemical properties of the materials. As these polymers only provide physical 
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supports, various ligands such as collagen, fibronectin, RGD, galactose or 
glucose have been conjugated to the substrates in order to recapitulate cell-
matrix interactions and to maintain hepatic functions [102]. Among them, 
galactose has garnered increasing interest due to its interaction with 
asialoglycoproteins (ASGPR) receptors.  ASGPRs are predominantly found in 
hepatocytes and their primary physiological function is to internalized galactose 
from circulating blood[103]. This unique characteristic of ASGPR makes it a 
popular candidate for liver drug targeting[104]. When ASGPR interacts with 
galactose ligands conjugated on a substrate, it allows hepatocytes to adhere to 
the surface without relying on integrin-mediated signalling pathway which may 
cause dedifferentiation [105]. Hepatocytes attached to galactose surface 
maintain their rounded morphology and migrate to form spheroids in the 
presence of epidermal growth factors (EGF). The hepatocytes spheroids formed 
on galactose modified substrate exhibited high liver of liver differentiated 
functions [106]. It has also been reported that apoptosis and necrosis was 
supressed in hepatocytes cultured on galactose modified scaffold. Taken 
together, galactose-conjugated substrate is a promising synthetic extracellular 
matrix candidate for hepatocytes cell culture.  
2.5.2 Microscale substrate manipulation with Micro-Electro-Mechanical 
Systems (MEMS) 
Microelectromechanical systems (MEMS) technologies originates from 
the semiconductor and microelectronics industry. It is able to routinely produce 
well-controlled features ranging from millimeters to submicronmeters [107]. 
Moreover, many surface chemical modification methods have been developed 
to render non organic materials used in the circuit industry such as silicon to be 
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more biocompatible [64, 108, 109]. Given its ability to precisely control the 
physical/mechanical and chemical environments, MEMS has been garnering 
increasing attentions for biomedical applications.   
The scope of MEMS fabrication and applications is extremely wide and 
beyond the scope of this thesis. We will instead focus on the fabrication methods 
and materials related to the work.   
2.5.2.1 MEMS fabrication methods 
Most MEMS fabrication techniques have their roots in the standard 
manufacturing methods developed for the semiconductor industry, which is 
considered “hard” micromachining. This terminology is created as oppose to 
the more recent microfabrication method of “soft” micromachining such as 
micromoulding  or hot embossing [110, 111]. Soft micromachining is routinely 
used in creating PDMS microfluidic chips or surfaces with defined topography 
in time and cost efficient manners [107]. However, soft micromachining has 
difficulty reproducing geometries with high aspect ratio and/or small features.  
In our work, microfabricated membranes are created with “hard” 
micromachining. It typically involved three steps: (1) thin film deposition, (2) 





Figure 2. Microfabrication process. Reprinted from [112], Copyright 2015, 
with permission from Elsevier.  
 
First, a thin film is deposited on a substrate (usually a silicon wafer). 
There are three main thin-film deposition techniques: (1) oxidation, (2) 
chemical vapour deposition (CVD), and (3) physical vapour deposition (PVD). 
Oxidation is typically carried out by heating substrates at 800°C-1200°C in 
atmosphere containing O2 or H2O vapour, which resulting in a thin layer of 
oxide such as SiO2. Chemical vapour deposition such as Low Pressure (LPCVD) 
and Plasma Enhanced CVD (PECVD) utilized chemical reactions in gas phase 
to form deposited thin film. These methods are used to deposit inorganic 
materials such as silicon oxide, silicon nitride and polycrystalline silicon. 
LPCVD is performed at high temperatures of 550-990°C, resulting in high 
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stoichiometric and conformal thin films. PECVD is carried out in plasma 
systems at much lower temperature but the resulting films are less conformal. 
Physical vapour deposition involved either evaporating the deposited materials 
in a heated chamber containing the substrates or bombarding the materials with 
high energy inert ions causing the individual atoms removed from the materials 
surface and ejected towards the substrates.  
Next photolithography was carried out. Photolithography is a technique 
where a pattern was transferred to a substrate using light. This is done by first 
coating a photosensitive resists materials on top of the substrate. The photoresist 
will be subjected to soft bake to remove the solvents from the resists and to 
improve adhesion. A mask with the desired patterns will then be aligned to the 
substrate and the photoresist is exposed to a UV light source. Depending on 
whether the photoresist is “positive” or “negative”, the UV-exposed or un-
exposed regions will be removed. The resist is subsequently hard baked to 
improve the adhesion. The pattern on the photoresist will then be used as a 
protection mask in subsequent etching steps.  
Etching transfers the photoresist pattern to the target materials. The 
choice of etching process depends on the selectivity and directionality required. 
Wet etching techniques such as potassium hydroxide (KOH) and tetramethyl 
ammonium hydroxide (TMAH) show high etching selectivity on the etching 
materials but have less aniosotropic etch. Dry etching techniques such as Ion 
milling, High Pressure Plasma Etching, and Reactive Ion Etching (RIE) have 
small undercut and high anisotropicity. Ion milling utilizes accelerated inert 
ions bombarding perpendicularly to the surface to remove materials. It has very 
low etch rate and poor selectivity. High Pressure Plasma Etching etches by 
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creating highly reactive species that react with the materials to be etched; the 
product of the reaction is highly volatile which diffuses away immediately. 
Reactive Ion Etching first activates the surface with plasma before 
bombardment of ions, thus increasing the etch rate.  
Once the desired pattern is created on the substrate, the photoresist is 
removed by organic solvents.  
2.5.2.2 MEMS materials 
Traditionally, silicon is the major materials used in MEMS given its 
important role in semiconductor industry. However, polymers such as 
polydimethylsiloxane (PDMS), polycarbonate and polyimide have been gaining 
increasing interest due to their comparatively low cost, which makes 
disposables device possible while their wide variation in mechanical properties 
also offers alternative interfaces to silicon and glass’ hard and rigid surfaces. 
Here we reviewed the two materials used in our work: silicon and parylene.   
2.5.2.2.1 Silicon 
Silicon is the traditional choice of MEMS materials given its 
background from the semiconductor industry. As a results, silicon 
micromachining technique is well developed and many BioMEMS devices such 
as biosensor, microneedle, microfluidic chip, polymerase chain reaction chip 
etc. have been reported.  
Single crystalline silicon wafer, most commonly used in MEMS is hard 
and brittle. The same attributes can be observed in other silicon derivatives such 
as silicon oxide, silicon nitride and silicon carbide (Table 5). Due to its electrical 
properties, silicon may have dual use of being a structural material and a 
semiconductor in a MEMS device. However, silicon itself is not a good cell 
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culture candidate, as cells cannot readily attach to its polished surface. However, 
many surface modification methods such as plasma deposition [113] or covalent 
modification using silane is able to bound cell adhesive ligands to the 
surface[114], making it cell culture compatible.  
Table 5. Mechanical properties of silicon and silicon derivatives. 




Silicon 160 7 
Silicon oxide 73 8.4 
Silicon nitride 323 14 
Silicon carbide 450 21 
 
Native silicon dioxide forms immediately on the bare surface of silicon 
when exposed to oxygen. In MEMS, silicon dioxide is thermally grown by 
exposing silicon wafer to oxidizing atmospheres at temperatures above 800°C. 
Silicon oxide is routinely used as insulators and sacrificial layers in 
micromachining.    
Silicon nitride is deposited through plasma enhanced chemical vapour 
deposition (PECVD) or low pressure chemical vapour deposition (LPCVD). It 
is a well-known material for cell attachment [115]. As silicon nitride is resistant 
to alkaline etch processes, it is a good masking material which can be used to 
fabricate membranes [116]. 
Silicon carbide is also deposited through plasma enhanced chemical 
vapor deposition (PECVD) or low pressure chemical vapor deposition 
(LPCVD). Similar to silicon nitride, it also has low etching rates in KOH and 
HF solution. Cell cultures membranes utilizing silicon carbide have also been 
reported[117].  
All silicon materials have been evaluated for biocompatibility and was 
found they are generally non-toxic [118]. The biggest problem faced by silicon-
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based BioMEMs is their relatively high cost, making disposable device cost 
inefficient. Their brittleness also poses a major issues in constructing a robust 
device.  
2.5.2.2.2 Parylene 
Parylene is the tradename for a variety of poly(p-xylylene) polymers 
(Figure 3). Among them, parylene N has the highest dielectric strength and most 
penetration factors and conformability, but has a low threshold temperature of 
40°C. Parylene C has the best biocompatibility (FDA Class VI) and good 
thermal stability with threshold temperature of 90°C. Parylene D has slightly 
higher threshold temperature (135°C) but lower biocompatibility and 
conformability. 
 
Figure 3. Chemical structures of Parylene N, C and D. 
 
Parylene has been used substantially for various coating applications, 
especially in medical device coating [119]. This is done by depositing parylene 
onto target substrates using chemical vapour deposition developed by Gorham 
[120]. The process is done in room temperature, thus making it favourable for 
thermal-sensitive substrates. The end product is a conformal, uniform and 
pinhole free films that able to penetrate deep into crevices. Its low permeability 




Compared to other polymers, parylene possesses significant advantage 
in its machinability. The thickness of the coating can be controlled, ranging 
from several hundred angstroms to 75 microns.  Parylene is compatible with 
most MEMS fabrications technologies, allowing micro or even nano scale 
structures to be precisely built on parylene backbone.  
Parylene thin films possess few advantages that makes it an ideal 
candidate for cell culture. It is mechanically strong with Yong’s modulus of 2.8-
4GPa and has high malleability that can withstand up to 200% elongation, 
allowing it to create various structures that doesn’t break easily. It is transparent 
to visible light, which eases optical observation of cultured cells. More 
importantly, despite its chemical inertness, parylene C can be modified with 
oxygen plasma and subsequently undergoes silanisation which allows 
conjugation of biomolecules to support cell growth[121, 122]. 
2.6 Product design and development 
2.6.1 The need for product design and development in tissue engineering 
Despite more than 20 years of research and development, with more than 
$11 billions of research funding, successful tissue engineering products are still 
extremely rare [123]. The possible causes of such gap between research and 
commercialization come in many forms, including hurdles to gain approval for 
clinical application, difficulty in getting acceptance of product, competition 
from less advanced yet cheaper alternatives, difficulty to get funding for scale-
up and manufacturing process.  However, logistical and technical issues aside, 
one of the most fundamental barriers that stands in between research and 
product might be the way tissue engineering research is conducted [123].  
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The conventional research to technology paradigm suggests that a 
technology development starts from basic research to applied research to 
development to production and operations2, with each of the successive states 
dependent upon the preceding ones [124]. According to this model, before a 
tissue engineering product such as a skin graft is developed, the researchers 
should have a complete understanding of skin cells biology and the attributes of 
the materials to culture the cells (basic research); the applied scientists would 
then culture the skin cells on different materials for different purposes 
(usability); while the engineers will scale up the productions by changing the 
specific parameters which he knows are going to affect the cells growth 
(scalability).    
However, the complexity of biological system makes complete 
understanding of the body a daunting task and important gaps still persist in the 
fundamental knowledge underlying tissue engineering [125].  At the same time 
the medical needs of tissues either for transplantation or drug testing requires 
substitutes urgently [126].  As a result, tissue engineering is forced to focus on 
developing biological substitutes instead of basic fundamental understanding 
prematurely [127]. Such situation means that the traditional research paradigm 
would not work for tissue engineering as the applied scientist and the 
development engineer do not have enough information to conduct their 
                                                 
2 The definition of basic research, applied research and development from Second Annual 
Report of the National Science Foundation Fiscal Year 1952 are as followed: Basic research – 
directed towards more complete understanding of nature and its laws, embarks upon the 
unknown, enlarging the realm of the possible; Applied research – elaborate and apply the 
knowledge. Convert the possible into actual, to demonstrate the feasibility of scientific or 
engineering, to explore alternative routes and methods for achieving practical ends; 
Developments – systematics adaptation of research findings into useful materials, devices, 
methods and process. 
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subsequent modification for usability and scalability; Applied scientists work 
mainly on the basis of ad hoc tinkering to come out with tissue engineering 
solutions [125], whereas development engineers run into various unforeseen 
problems when trying to scale up the same results obtained in lab. This is also 
the reason why a lot of tissue engineering researches fail between research and 
development. 
Given the uncertainty in tissue engineering downstream development at 
the current stage, it is important to minimize subsequent changes from research 
to development. This means that ideally, tissue engineering research should be 
conducted in a form closely mimicking its end product. Such realization 
requires tissue engineering scientist to design and develop a tissue engineering 
product with an end usage in mind.  However, designing and developing a 
satisfactory product is often not as straightforward and intuitive as one would 
expect. In fact, a large amount of product design and development literature has 
been dedicated in systematically translating end user requirements into product 
specifications [128]. In the case of tissue engineering, these systematic 
approaches is useful in helping the scientist in translating end user requirements 
into research guidelines [129].  
2.6.2 Product design and development 
Product design and development, which is defined by Ulrich as the 
transformation of a market opportunity into product available for sale, is a long 
process and encompasses operations from marketing to organization to 
operations management to engineering design [130]. Typically, the whole 
process can be broken down into three phases: pre-development, design and 
development process, and post-design and development [131].  
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Contrary to most people’s belief, product design and development does 
not begin with a new product idea. Instead, a successful product often stem from 
a thorough analysis and identification of opportunity. It is during the pre-
development phase where an opportunity is identified and evaluated with 
respect to the general requirements of the company. Opportunity can be sorted 
into four different categories: an underutilized resource, a new resource, an 
external challenge/opportunity or an internal mandate. This phase is strategic in 
nature, and decides whether one should embark on the new product 
development process [132]. 
The design and development process encompasses three sub-phases: 
concept development, design generation, and preproduction validation. During 
the concept development phase, customer needs are identified and converted 
into target specifications. Identifying customer needs requires inputs from the 
end user. The end users’ inputs are usually verbal and qualitative, which 
requires translation into specifications that spell out precise and measureable 
metrics [128]. Once the target specifications are set, a design that fit the 
boundaries will be generated during the design phase. A prototype of the design 
will be then generated and tested against the functional requirements. Lastly, 
the product should be tested in a form similar to the end product to ensure 
smooth transition of the design to end product[131]. 
 The post-design and development phase consists of 
production/distribution and post-sales services [131].  
2.7 Limitation of current in vitro hepatocytes culture model 
Although many in vitro hepatocytes culture models have been 
developed and showed considerable maintenance of differentiated functions as 
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reviewed in Chapter 2.4, most of them still can’t be adapted for industrial scale 
drug testing purposes because many of them are not designed with a specific 
aim in mind, which is crucial from product design and development point of 
view. Without a specific aim, the design specification of the culture model 
cannot be determined and the end product cannot fulfil user requirements. In 
our work, we identified industry scale drug testing as our main aim, which 
requires an in vitro hepatocytes culture model that is robust, high throughput 
and has high differentiated functions. Judging from these three criteria, the 
limitations faced by current in vitro models are: 
1. Sandwich culture model suffers from batch to batch variation of the 
extracellular matrices used to culture hepatocytes. The thick and 
uncontrollable top coating also creates a mass transfer barrier for drug 
assess, creating variation for drug testing results. 
2. Spheroids culture, depending on the model uses, possesses issues such 
as growing spheroids size, difficulty in manipulating floating spheroids, 
cell loss arising from non-adhesive surfaces. Hepatocytes spheroids 
cultured in scaffold or gel may avoid these problems but face drug 
access and drug absorption issues due to the bulky structures.  
3. Perfusion culture can enhance hepatocytes functions, yet many of them 
are not designed for drug testing usage in conventional well plate 
standard. A lot of the bioreactors also neglect the need of shielding 
hepatocytes from shear stress and/or engineering a more comprehensive 




3 Objective and aims: 
The main objective of this project is to develop a high throughput and 
robust drug screening platform using perfusion cultured hepatocytes. This 
research project differs from others as it does not follow the conventional linear 
model of research where basic materials research was first conducted, followed 
by general cell culture performance testing and finally optimizing the design for 
a specific target application. In contrast, drawing from product development 
literature, a target application is first identified. Defining a specific target 
application is one of the most underestimated challenges in translating tissue 
engineering research into tissue engineering products as it is often perceived 
that a good technology will have multiple applications [123]. However, what 
often has been overlooked is that shaping the design and manufacturing process 
for specific clinical application is lengthy and expensive. And in some cases, 
some of the technologies might even have fundamental handicaps that make 
them not applicable to the target applications at all. The main advantage of 
having a clear target application is that it allows the researcher to identify which 
are the important requirements that need to be met by their project and 
incorporate these designs into the early research stage. This can minimize 
drastic changes during the downstream development which might nullify the 
results generated earlier. The fine tuning of the materials and in depth research 
studies will only be conducted after we have a rough working prototype that 
fulfills the basic requirements. Finally, the working prototype will be tested 
against the target application to evaluate the usefulness of the project.  
Guided by the rationale mentioned above, I proposed to have the 
research to be broken down into 3 parts. The first part will focus on the design 
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of the hepatotoxicity testing platform and a preliminary testing of the design. In 
the second part, efforts will be focused on the fine tuning of materials. And in 
the third part, effort will be made to verify the behavior of hepatocytes in 
perfusion culture with the improved material configurations.      
3.1 Specific aim 1: Developing a drug testing platform that meets early 
stage drug screening requirements  
3.1.1 Hypothesis 
Bringing in product development methodologies into tissue engineering 
research during the early stage provides a systematic approach in translating end 
goals into research parameters, which helps to focus the research and increases 
chance of success.  
3.1.2 Rationale 
Transition of tissue engineering discovery from laboratory to industry, 
either for therapeutics or pharmaceutical screening, is challenging. With so 
much efforts focusing on the biological aspect of it, a lot of discoveries fail to 
address the downstream technical issues such as cost, usability, scalability and 
manufacturability that make them suitable for industry uses [133]. Such 
situation is also partly due to the traditional research paradigm that assumes 
transition from discovery to usability to manufacturing scalability is linear and 
sequential [134], where scientists focus on fundamental researches while 
engineers focus on product and process development. However, tissue 
engineering products are extremely sensitive to changes, making subsequent 
modifications to improve scalability or usability extremely difficult if not 
impossible [135, 136]. This creates a gap between tissue engineering research 
and tissue engineering products. One way to overcome the gap as proposed by 
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Hollister [123] is to conduct tissue engineering research with specific aim in 
mind[124] so that research design can be guided by having downstream 
considerations and refinements incorporated into part of the research.  
3.1.3 Research plan  
 Identify a target application and its requirements 
 Design a system that meets the target application requirements  
 Test the performance of the system against the requirements 
 
3.2 Specific aim 2: Optimizing hepatocytes spheroids culture 
configuration 
3.2.1 Hypothesis 
Optimizing the silicon nitride sandwich configuration with soft 
poly(ethylene glycol) gel can improve hepatocytes differentiated functions 
3.2.2 Rationale 
Our previous design has chosen to use galactose-modified silicon nitride 
membrane for its high structurally stability, high configurability and improved 
mass transfer. Previous works [76, 78] have shown that galactose ligands are 
conducive to spheroids formation. Spheroids cultures are multicellular 3-D 
aggregates that promote tight cell-cell interactions. Hepatocytes spheroids have 
shown to maintain high level of liver-specific functions such as albumin 
production, urea synthesis, cytochrome p450 and glucuronidation activity [16-
18]. Their structures are highly similar to those found in native liver tissue with 
established structural polarity and functional bile canaliculi[19].  To culture 
spheroids using silicon nitride sandwich culture configurations has 2 added 
advantages: First, it traps the spheroids at the bottom of the well in conventional 
well plate format. This allows higher throughput compared to handling floating 
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spheroids in suspension. Second, it constrains the size of the spheroids as they 
can’t move around freely and collide with each other as in the case of 
suspension-cultured spheroids.   
However our current study shows that the morphology of the Si3N4 
sandwich cultured hepatocytes differs considerably from conventional 
spheroids. When F-actin staining was conducted on the Si3N4 sandwich cultured 
hepatocytes, extensive stress fibers were formed at the hepatocytes facing 
silicon nitride membrane. Stress fibers formation indicates over-stretching and 
spreading of cells, which is detrimental to hepatocytes differentiated functions 
[137]. We hypothesize that such formation is due to the high stiffness of the 
silicon nitride membrane, as hepatocytes have shown to stretch and spread on 
stiff surface [138]. In this section of the study, we propose to modify the silicon 
nitride membrane with soft gel to shield the hepatocytes from the high stiffness 
of silicon nitride membrane. We will then show that by culturing the 
hepatocytes using the gel-modified silicon nitride sandwich aids spheroids 
formation and subsequently promotes the hepatocytes differentiated functions. 
Finally, we will subject the culture configurations to drug testing in order to 
demonstrate its usability for drug screening purposes.    
3.2.3 Research plan 
 Develop a surface modification scheme to incorporate soft gel 
onto the surface of silicon nitride membrane 




 Demonstrate improved hepatocytes differentiated function in 
gel-modified sandwich-constrained spheroids compared to non-
gel modified sandwich constrained spheroids 
 Demonstrate improved drug testing capability in gel-modified 
sandwich-constrained spheroids compared to non-gel modified 
sandwich constrained spheroids 
3.3 Specific aim 3: Create a perfusion-cultured sandwich-constrained 
spheroids model 
3.3.1 Hypothesis 
A synergistic effect from high cell-cell interactions from spheroids 
culture and efficient mass transfer condition from perfusion culture will create 
an optimum hepatocytes cell culture platform 
3.3.2 Rationale 
Spheroids model has shown to be able to maintain hepatocytes 
differentiated functions and polarity reestablishment, probably due to its high 
cell-cell interactions. However, the multicellular structures of spheroids poses 
significant challenge to effective mass transfer of oxygen, nutrients and waste. 
We hypothesize that introducing perfusion flow to spheroids culture will elevate 
the mass transfer problem in spheroids since perfusion culture is able to 
transport oxygen, nutrients and waste more efficiently. However, most 
hepatocytes spheroids culture model are not designed to be incorporated into 
perfusion culture, not to mention downstream drug testing. For example, 
spinning or rotating hepatocytes spheroids culture method will create spheroids 
that grows bigger as hepatocytes spheroids collide together, introducing cell 
count variation into drug testing. Other spheroids culture methods utilize 
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biological, chemical or microfabricated surfaces with typically has adhesion 
properties and hepatocytes spheroids can be washed off easily. In the previous 
section, we have developed a sandwich-constrained spheroids culture 
configuration. This configuration is specifically designed so that it can maintain 
the spheroids morphology and cell count between two layers of membranes that 
can be easily transferred between static well plate and perfusion bioreactor. In 
this part of the study, we would like to verify whether subjecting this sandwich-
constrained spheroids configuration to perfusion culture will improve 
hepatocytes function in vitro.  
3.3.1 Research Plan 
 Optimizing perfusion condition for sandwich-constrained 
spheroids 
 Demonstrate improved differentiated function such as urea and 
albumin synthesis in perfusion-cultured sandwich-constrained 
hepatocyte spheroids 
 Demonstrate improved polarity maintenance in perfusion-





4 Developing a robust and high throughput sandwich cell 
based drug screening platform 
4.1 Introduction 
Transition of tissue engineering discovery from laboratory to industry is 
challenging. The complexity of fully understanding biological, chemical or 
even mechanical system required to develop a tissue engineering products is 
daunting and important gaps still persist in fundamental knowledge [125], 
hindering smooth transition from basic research to applied research to product 
development in tissue engineering. To overcome the gap, Hollister [123] 
proposed that one should conduct tissue engineering research with specific aim 
in mind[124].  
In this work, we plan to develop a platform for hepatocytes-based drug 
metabolism and hepatotoxicity screening platform due to urgent need in 
pharmaceutical industry where bioavailability and toxicity are still the major 
barriers in drug development [139]. Unlike other in vitro liver cell culture model 
such as bioartifical liver assist device (BLAD) or culture model developed to 
understand liver biology, a liver cell culture model for drug testing requires 
different set of criteria. First, the expansion of combinatory chemistry and 
genomic understanding fuels a rapid growth of novel compound, which 
demands a scalable and high throughput drug screening methods [5]. Second, 
in order for the drug testing results from different experiments to be comparable 
(ie. High reproducibility), the cell culture platform has to be robust with 
minimal variation from batch to batch [140]. Based on these requirements, we 
identified three important criteria for our system: (1) high differentiated 
functions, (2) high throughput and (3) high robustness. 
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Here we develop a high throughput and robust drug-induced 
hepatotoxicity screening platform (RoboTox) using perfusion sandwich-
cultured hepatocytes that is carefully designed to fulfil all three criteria 
mentioned above.    
4.2 Materials and methods 
4.2.1 Materials 
100 μm thick biaxially oriented polyethylene terephthalate (PET) films 
were purchased from Goodfellow Inc. (Cambridge, UK). The galactose ligand, 
1-O-(6’-aminohexyl)-D-galactopyranoside (AHG, M.W. 279) was synthesized 
as described previously [79, 141] and verified by NMR spectrum. All other 
chemicals were purchased from Sigma-Aldrich (Singapore) unless otherwise 
stated. Low stress porous Si3N4 membrane was designed, fabricated, surface 
functionalized and characterized as described previously [116, 142]. 
4.2.2 Primary rat hepatocytes isolation and culture 
Hepatocytes were harvested from male Wistar rats weighing 250-300 g 
by a two-step in situ collagenase perfusion method [143]. Animals were handled 
according to the Institutional Animal Care and Use Committee (IACUC) 
protocol approved by the IACUC of the National University of Singapore. Only 
hepatocyte with viability of >85% as determined by Trypan Blue exclusion 
assay. Freshly isolated hepatocytes were seeded onto collagen-coated or 
galactose-immobilized PET films at 1×105 cells/cm2 in a 96-well plate. The 
cells were cultured in William’s E medium supplemented with 10 mM NaHCO3, 
1 mg/ml BSA, 10 ng/ml EGF, 0.5 μg/ml insulin, 5 nM dexamethasone, 50 ng/ml 
linoleic acid, 100 units/ml pencillin and 100 μg/ml streptomycin; and incubated 
with 37˚C, 5% CO2, 95% humidity for 24 hours. Collagen sandwich was 
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assembled by placing a collagen-coated polycarbonate membrane (Isopore™, 
Milipore, USA) on top of the hepatocytes seeded on collagen-coated PET film. 
Si3N4 sandwich culture was assembled by placing galactose-immobilized 
porous Si3N4 membrane (20 μm pore size and 20 μm inter-pore distance, 
corresponding to 20% porosity) on top of the cells on galactose-immobilized 
PET films.  
4.2.3 RoboTox platform 
Hepatocytes were first seeded on galactose-immobilized PET film for 
24 hours, and then overlaid with galactose-immobilized porous Si3N4 
membrane. Hepatocytes were cultured in this Si3N4 sandwich culture 
configuration for another 24 hours before transferring into the RoboTox 
bioreactor. The bioreactor comprises of three subunits: an upper lock plate, a 
middle sieve plate and a lower perfusion bioreactor. It was machined to 
dimension from a polycarbonate block and sealed with o-rings and screws. The 
lower perfusion bioreactor was fabricated according to the dimension of a 
typical 96-well plate, except the wells are interconnected in series by a 3 mm 
diameter fluid channel. The wells of the middle sieve plate are slightly smaller 
than the wells of lower perfusion bioreactor so that they can fit into the 
bioreactor and conventional 96-well plate. The middle sieve plate holds the 
Si3N4 sandwich and facilitates easy transfer of the cells between the perfusion 
bioreactor and standard 96-well plate. The upper lock plate provides uniform 
pressure to seal the entire assembly.  To improve the delivery of oxygen which 
is important for hepatocyte culture [144], circular openings corresponding to the 
bioreactor wells were drilled into the upper lock plate. An oxygen permeable 
membrane (Breathe-Easy®, Diversified Biotech, USA) was placed between the 
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sieve plate and the upper lock plate to preserve the closed circuit while allow 
adequate oxygen diffusion at the same time. The bioreactor was connected to a 
recirculating closed perfusion loop so that it is isolated from the external 
environment. The perfusion loop consists of RoboTox bioreactor, medium 
reservoir, peristaltic pump (Ismatec SA, Switzerland), three-direction valves 
(Upchurch Scientific, USA), stopping valves (Upchurch Scientific, USA), 
connectors (Upchurch Scientific, USA) and oxygen-permeable silicone tubing 
(Ismatec SA, Switzerland), and placed in a 37˚C incubator with 5% CO2 and 
95% humidity. Online sampling and monitoring was achieved via three-
direction valve. For high-throughput drug testing, the middle sieve plate holding 
the perfusion-cultured Si3N4 sandwiches were removed from the bioreactor and 
placed into the conventional 96-well plate for multiplex drug testing using 
robotic liquid handle.   
4.2.4 Mass transfer efficiency measurement 
Mass transfer efficiency was measured by limited diffusion of cell 
labelling agent CellTracker™ Green (Invitrogen, USA). Hepatocytes were first 
thoroughly labeled with 20 M CellTracker ™ Orange (Invitrogen, USA) in 
culture media. The media was replaced with 2 M of CellTracker™ Green 
under static and perfusion condition for 2 hours. The cells were rinsed with 
phosphate buffered saline (PBS) and fixed with 3.7% paraformaldehyde. Z-
stack images from three independent experiments were taken with confocal 
microscope (Fluoview 300, Olympus, Japan). Quantification of the labelled 
cells was performed by Matlab (R2009a). After removing noise using a low-
pass filter, z-stacks of binary masks were created by thresholding the red 
channel images. Zero values in the mask represent background; while red 
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signals represent the space occupied by cells. The total cell area for one z-stack 
was defined to be the total number of all positive pixels in the corresponding 
masks. Mass transfer was represented by total intensity in the green channel. 
Total intensity was defined as the sum of all pixel intensities in the positive 
areas of the corresponding green channel. The mass transfer efficiency was 
calculated by total intensity/total cell area.  
4.2.5 Cell viability measurement 
Cell viabilities of primary rat hepatocytes cultured in RoboTox system 
for 6 days at the flow rates of 0.1, 0.06, 0.03, 0.015 ml/min were assessed by 
live and dead staining of the cells with Calcein-AM (Molecular Probes, USA) 
and propidium iodide (PI). Cells were washed with PBS and incubated with 5 
mM of Calcein AM and 25 mg/ml of PI in culture medium at 37 °C for 30 min. 
Cells were then washed with PBS, placed in fluorescent mounting medium 
(Dako, Denmark) and viewed by confocal microscopy (Fluoview 300, Olympus, 
Japan). Cell viability was also measured by CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (MTS Assay, Promega, USA). 
4.2.6 Drug-induced hepatotoxicity testing 
For IC50 measurement, hepatocytes were treated with APAP, diclofenac, 
ketoconazole, chlorpromazine, flutamide or quinidine for 24 hours and cell 
viability was measured using MTS assay. Robotic liquid handling system 
(Figure 1D; customized by Bio Laboratories, Singapore) was used to perform 
drug testing. Detailed configuration of the system and protocol are described in 
supplementary materials and methods. 
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4.2.7 Statistical methods 
Data from at least two independent experiments were analyzed and 
values were represented as mean ± standard error of means (s.e.m.). The Student 
t-test was used to analyze the statistical significance of specific pairs of the data. 
Result with a p value less than 0.05 were considered statistically significant. 
One-way ANOVA test was used to analyze the significance of differences 
among multiple groups of data. P value less than 0.05 was considered 
significantly different. 
4.3 Results 
4.3.1 Platform development considerations and final design of robust and 
high throughput drug-induced hepatotoxicity platform (RoboTox) 
We recognize that in order for a hepatocytes cell culture model to be 
used for drug screening purposes, it has to be robust and high throughput, 
besides maintaining hepatocytes differentiated functions. To fulfill all three 
requirements, the following design approaches as shown in Table 6 were taken.  
Table 6. Design approaches to fulfil requirements of RoboTox. 
Requirements Design Approach 
Differentiated cellular 
functions 
 Sandwich culture configuration 
 Perfusion medium flow 
Robustness  Replacement of collagen with Gal-Si3N4 
 Perfusion culture 
High Throughput  96-well plate design which is compatible 
with robotic liquid handler 
 Decoupling of culture flow and drug 
flow 
 
Briefly, in order to maintain hepatocytes differentiated functions, 
hepatocytes are cultured in sandwich culture configurations .To further improve 
hepatocytes function, perfusion medium flow is included to improved oxygen 
and nutrients delivery as well as efficient waste removal[21]. Robustness is 
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improved by replacing collagen with galactosylated Si3N4 sandwich since 
collagen tends to suffer from batch to batch variations [145] and uneven mass 
transfer [34]. The uses of perfusion flow has also shown to demonstrate 
consistent drug response at different culture time points as it able to maintain 
basal CYPs for longer period [23]. To achieve high throughput, the platform is 
designed according to conventional 96-well plate format so that it can be 
incorporated into robotic liquid handler. More importantly, we cultured 
hepatocytes in a sieve plate that allows easy transfer of cells from perfusion 
bioreactor to drug testing well plate. By decoupling cell culture flow and drug 
testing flow, it allows the platform to take advantage of perfusion flow without 
sacrificing throughput capacity.  
The final design is shown in Figure 4. Hepatocytes are cultured in 
galactosylated Si3N4 sandwich (Figure 4A), which is placed in a bioreactor 
connected to perfusion culture flow. The bioreactor comprises of three subunits: 
an upper lock plate, a middle sieve plate and a lower perfusion bioreactor 
(Figure 4B) and is designed according to the dimension of 96-well plate. For 
cell culture, Si3N4 sandwich-cultured hepatocytes are placed in the sieve plate, 
which is assembled together with the upper lock plate and lower perfusion 
bioreactor and connected to the circulatory medium reservoir (Figure 4C). To 
conduct drug testing, the middle sieve plate holding the perfusion-cultured 
Si3N4 sandwiches were removed from the bioreactor and placed into the 








Previously, our lab has demonstrated that rat hepatocytes cultured in the 
RoboTox platform exhibited enhanced differentiated function such as better 
urea production (Appendix 9.1, Figure 52) and higher CYP1A1/2 enzymatic 
Figure 4.  Schematic diagram of RoboTox platform for hepatocytes 
sandwich culture and drug testing. Reprinted from [1], Copyright 2014, with 
permission from Elsevier. 
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activities (Appendix 9.1, Figure 53) compared to collagen sandwich cultured 
hepatocytes. It has also shown higher sensitivity and reduced variation toward 
drug-induced toxicity. (Appendix 9.2, Figure 54, Figure 55). However, its 
robustness and high-throughput capability has not be shown. In current work, 
we will measure the effectiveness of the RoboTox platform in delivering a 
robust and high throughput drug testing platform. 
4.3.2 High mass transfer efficiency in RoboTox platform  
Despite its ability to maintain hepatocytes differentiated functions, 
collagen sandwich culture suffers from batch to batch collagen variations [145], 
variable drug absorptions [34] poor mass transfer across collagen gel especially 
in static culture over extended culture period [146]. We intend to remove such 
variation and thus improve the robustness of the sandwich culture by replacing 
collagen with galactosylated Si3N4 membrane. We measure the effects by 
comparing the mass transfer efficiency experienced by the hepatocytes cultured 
in collagen sandwich, Si3N4 sandwich and RoboTox perfusion platform. The 
cell labeling dye (2 M CellTracker Green) was introduced with 1/10 the 
normal concentration into the culture medium for 2 hours and the degree of cell 
labeling (fluorescent intensity) was quantified as a measure of the mass transfer 
efficiency (Figure 5). Hepatocytes cultured in collagen sandwich exhibited the 
least fluorescence intensity (ie. lowest mass transfer efficiency) as the dye 
penetration might be partially blocked by the collagen gel. Si3N4 sandwich 
cultured hepatocytes in static culture showed higher mass transfer efficiency 
than the cells in collagen sandwich The hepatocytes cultured in RoboTox 





Figure 5. Confocal images of (i) collagen sandwich, (ii) Si3N4 sandwich and 
(iii) RoboTox-cultured hepatocytes after exposed to 2µM CellTracker™ 
Green for 2 hours. Reprinted from [1], Copyright 2014, with permission from 
Elsevier.   
 
Quantification of the fluorescence intensity revealed that mass transfer 
efficiency was 2.5 times higher in Si3N4 sandwich static culture; and 5.5 times 
higher in RoboTox culture compared to the collagen sandwich culture control 
(Figure 6).      
 
Figure 6. Quantification of fluorescence intensity of collagen sandwich, Si3N4 
sandwich and RoboTox-cultured hepatocytes. Data plotted represent the mean 
± s.e.m of 3 independent experiments. *: p < 0.05. Reprinted from [1], 




4.3.3 High uniformity of nutrient access among serially-connected wells 
Since the RoboTox system is designed for parallel high throughput drug 
testing, the uniformity of the cells cultured across different wells in the 
bioreactor is important as the data from each well has to be cross-compared. In 
the bioreactor, 8 wells are connected in series for each perfusion loop. To 
investigate the uniformity of nutrient access among the serially-connected wells, 
cell labeling dye was allowed to perfuse through the system for 2 hours, and 
images of cells from each well were acquired and analyzed. Fluorescence 
intensity per cell area among the cells from different wells show no significant 
difference (One-way ANOVA p value = 0.20476; Figure 7).  
 
Figure 7. Uniformity of mass transfer efficiency as indicated by florenscence 
intensity of hepatocytes cultured in 8 serially-connected wells. Data plotted 
are the mean ± s.e.m of 3 independent experiments. Reprinted from [1], 




4.3.4 High uniformity of cell viability among serially-connected wells 
We also measured the viability of hepatocytes cultured in different wells 
of the RoboTox for 2 days using MTS assay. The p-value from the one-way 
ANOVA analysis is 0.42664, indicating that there is no significant difference in 
cell viability for cells from different wells (Figure 8). 
 
Figure 8. Uniformity of cell viability of hepatocytes cultured in 8 serially-
connected wells. Data plotted are the mean ± s.e.m of 3 independent 
experiments. Reprinted from [1], Copyright 2014, with permission from 
Elsevier. 
     
4.3.5 Setting up robotic liquid handler for measuring IC50 values  
The robotic liquid handling system was customized by BioLaboratories 
as shown in Figure 9, which includes JANUS automated liquid dispensing 
station (96-well pipettor) housed within a biosafety cabinet, Tecan Safire 
monochromator microplate reader, Catalyst Express central robotic arm, 
Cytomat incubator etc. 
The whole IC50 values measurements on the robotic liquid handler was 
broken down into 4 separate processes: First, serial dilution of drugs were 
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conducted. Second, diluted drugs were added to hepatocytes. Third, MTS 
solution was added to hepatocytes. And finally, MTS results were read. The 
detailed process can be found in Appendix 9.3.  
To prepare serial dilution of selected paradigm compounds, 1 ml of drug 
solution with highest concentration was added into the first row of a deep well 
plate manually. The remaining wells on the drug dilution plate will be filled 
with 666 µl of culture media, transferred from the culture medium reservoir 
using the robotic liquid handler. The serial dilution was conducted by the robot 
by transferring and mixing 333 µl of drug solution from the previous row to the 
next row. The transferring was repeated for 6 times, generating a decreasing 
gradient of drug concentration as the pipettor move towards to the second last 
row of the plate. No drug was transferred into the last row of the plate, thus 
keeping the drug concentration on the last row as zero. 
Next, RoboTox bioreactor was dissembled and the hepatocytes were 
transferred to 96-well plate via the sieve plate. 100 µl of diluted drug solution 
from the drug dilution plate prepared previously were added to the cells using 
the robotic liquid handler. The 96-well plate with cells were then sent to 
incubator for incubation using the robotic arm. 
After 24 hours of drug incubation, the 96-well plate with cells were 
removed from the incubator by the robotic arm and placed inside the biosafety 
cabinet. The sieve plate holding the cells was removed from the 96-well plate 
and dried briefly on a sterile sponge before transferring to a new 96-well plate 
manually. 100 µl of MTS solution were then added to the cells by the robotic 
liquid handler and sent for incubation using the robotic arm. 
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After 1 hour of MTS incubation, the robotic arm removed the plate with 
cells from the incubator. The sieve plate holding the cells was removed 
manually. The colour of the remaining MTS solution in the 96-well plate was 
sent to be read by Tecan microplate reader using the robotic arm.  
 
Figure 9. Flat diagram of the robotic liquid handler layout. 
 
4.3.6 Measuring IC50 values of 6 paradigm compounds using RoboTox 
and robotic liquid handler 
To demonstrate high throughput capacity of RoboTox, we chose to 
measure IC50 values of various paradigm compounds. IC50 test was chosen for 
this purpose because it requires large amount of cell culture samples, ie. 
Minimum 8 biological samples in duplicates, which is logistically prohibitive 
in most other hepatocytes perfusion culture model.  
In total, the IC50 values of 6 paradigm compounds (APAP, ketoconazole, 
diclofenac, chlorpromazine, flutamide and quinidine) were evaluated. The 
drugs were chosen on the criteria that they are well characterized and they elicit 
toxicity by different mechanisms and are metabolized by different cytochrome 
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p450 (Table 7) [147]. The IC50 values obtained from RoboTox was compared 
to those from collagen sandwich culture [34] and with the reported IC50 values 
from literatures (Table 7). The IC50 values are in agreement with those reported 
in the literatures and the values from RoboTox are generally the lowest, 






Table 7. IC50 values measured using RoboTox, collagen sandwich culture and 
published IC50 values for 6 paradigm hepatotoxic drugs and their reported 









IC50  (µm) 
Mechanism of action 
APAP 7000 30000 14000 Formation of NAPQI 
mediated by CYP2e1 
[148] 
Ketoconazole 25 70 62.3 Oxidative stress by 
glutathione depletion 
[149] 
Diclofenac 180 400 263 Formation of 
benzoquinone and 
imine by CYP2c [150] 
Chlorpromazine 23 110 45.5 T-cell mediated 
killing, mitochondrial 
balance and CYP1a2 
inducer [147] 
Flutamide 30 90 75 Formation of 4-
hydroxy radical 
mediated by CYP1a2 
[151] 
Quinidine 170 250 457 Hepatitis and 
formation of sulphate 






Figure 10. Hepatotoxicity responses to (A) APAP, (B) Ketoconazole, (C) 
Diclofenac, (D) Chlorpromazine, (E) Flutamide and (F) Quinidine were 
evaluated using RoboTox and robotic liquid handler. : Collagen sandwich, 
: RoboTox. Data plotted represent the mean ± s.e.m of 3 independent 





Transition of tissue engineering discovery from laboratory to industry is 
challenging. The complexity of fully understanding biological, chemical or 
even mechanical system required to develop a tissue engineering products is 
daunting and important gaps still persist in fundamental knowledge [125], 
hindering smooth transition from basic research to applied research to product 
development in tissue engineering. To overcome the gap, Hollister [123] 
proposed that one should conduct tissue engineering research with specific aim 
in mind[124]. In our work, we focus on developing a platform for hepatocytes-
based drug metabolism and hepatotoxicity screening platform due to urgent 
need in pharmaceutical industry where bioavailability and toxicity are still the 
major barriers in drug development. [139]. 
Our results demonstrate a robust, high throughput drug screening 
platform that potentially meet industry-scale drug screening needs. In vitro liver 
model for drug screening has different set of criteria compared to liver tissue 
engineering for other purposes. In addition to good cellular functions, the liver 
tissue culture must be handled in large quantity in parallel (ie. high-throughput), 
and in an efficient and reproducible manner (ie. robust)[140]. We used the 
sandwich culture configuration to reestablish cellular functions of isolated 
hepatocytes. Sandwich culture has been shown to reestablish and maintain 
xenobiotic biotransformation capacity which is crucial for drug testing [12]. It 
also forms and maintains the cell polarity [11] which is important for drug-
transporter interactions investigations. However, the batch to batch variation of 
collagen isolation[145, 153], intrinsic instability of collagen gel [79], poor mass 
transfer over extended culture period [146] uneven drug absorption and drug 
56 
 
access of the collagen gel [34] lead to increase in drug testing variations. To 
create a robust system, we minimized such variations by replacing overlaying 
collagen gel with galactosylated microfabricated silicon nitride (Si3N4) 
membranes. Silicon nitride membrane has good chemical inertness, high 
fracture toughness and high wear resistance [154], allowing it to stay intact in 
the perfusion culture. This is important to stabilize the sandwich culture in the 
perfusion system and provide secure shield for hepatocytes from perfusion shear 
stress. The membrane was fabricated using Micro-Electro-Mechanical Systems 
(MEMS) technology which is highly reproducible with micrometer scale 
precision [155]. The fabricated membrane is ultra-thin (3µm), highly porous (20% 
porosity) and has uniformly distributed pores, which facilitates efficient and 
uniform mass transfer while minimizing drug absorption. Galactose ligands 
were stably conjugated to PET films and Si3N4 membranes via chemical 
reactions [75, 156], maintaining the differentiated hepatocytes functions via 
interactions with asialoglycoprotein receptors [77, 79] throughout the perfusion 
culture period. The perfusion culture system further enhances hepatocyte 
functions; specifically, CYP1A1 and CYP1A2 activities were significantly 
higher for hepatocytes cultured in RoboTox platform compared to those in static 
culture (Appendix 9.1, Figure 53). CYP1A1 and CYP1A2 are part of the 
cytochrome p450 (CYPs) family, which are involved in drug metabolism [157] 
by converting relatively nonpolar compound to polar compound for excretion. 
Some of the intermediate metabolites from drugs metabolism are chemically 
reactive and play a key role in drug-induced hepatotoxicity [47]. We tested the 
toxicity responses of 2 model CYPs-mediated hepatotoxicity drugs, APAP and 
diclofenac. Hepatocytes cultured in RoboTox platform displayed higher 
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sensitivity towards APAP and diclofenac-induced hepatotoxicity (Appendix 9.2, 
Figure 54). Further work is required to understand the mechanism of toxicity 
through the determination of drug sensitivity in the presence of CYP 450 
inhibitors such as Furafylline (CYP1A inhibitor) [158] or ketoconazole 
(CYP3A inhibitor) [159]. Demonstrating reduced sensitivity to other drugs such 
as Caffeine [160] that are rendered non-toxic by hepatocytes can also shed light 
into the mechanism of toxicity. We also tested the ability of perfusion culture 
in maintaining hepatocyte functions over longer period. CYP2E1 is one of the 
CYP450s that will deteriorate rapidly within a week even when the hepatocytes 
are cultured using sandwich configuration [62]. APAP forms NAPQI mainly 
through the CYP2E1 pathway [148]. We tested the CYP2E1-mediated 
hepatotoxicity on days 4, 8 and 14 of culture and found that the toxicity 
responses displayed by RoboTox-cultured hepatocytes were comparable 
throughout the three time points while static-cultured hepatocytes display 
significant different responses over different days (Appendix 9.2, Figure 55). 
This shows that basal CYP450s activity is maintained for longer period, which 
is important for minimizing drug screening variation caused by functional 
fluctuation or deterioration.  
High-throughput is another basic requirement for in vitro liver models 
in industry-scale drug screening [161]. Although perfusion culture is able to 
maintain and promote hepatocytes functions in vitro, incorporating it into high-
throughput testing platform is challenging as the total amount of setup time 
increases exponentially with the increasing number of tests performed. A 
conventional perfusion culture system that uses the same fluidic flow for culture 
medium delivery and drug delivery creates a coupled design where a design 
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parameter (ie. perfusion culture flow) has contradicting effects on 2 different 
functional requirements: positive effects for maintaining cell functions while 
negative effects for scalability or vice versa. A coupled design which does not 
satisfy Suh’s independence axiom compromises the overall functionality [162], 
eg. High-throughput capacity. To resolve the conflicts, the design must be 
decoupled so that different or even contradicting optimization process can be 
implemented to achieve the optimal high-throughput capability within each 
requirement constraints [163, 164]. Here decoupling was achieved by 
distinguishing and separating media culture flow and the drug delivery flow of 
RoboTox platform. For cell culture, perfusion flow is crucial for maintaining 
hepatocyte differentiated functions while individual fluidic flow is less 
important. Therefore, the wells of the perfusion bioreactor are interconnected in 
series by a single fluidic channel, allowing one fluidic setup to provide for 
multiple Si3N4 sandwiches. This decreases the total number of fluidic 
connections needed and increases the scalability of the design [165]. There was 
no significant difference in terms of the nutrient accessibility and cell viability 
among the cells cultured in series (Figure 7 and Figure 8). For high-throughput 
drug testing, individual fluidic flow becomes important for multiplex testing 
while perfusion flow is less crucial as drug exposure period are short. The 
perfusion-cultured Si3N4 sandwiches were transferred to conventional 96-well 
plate so that each Si3N4 sandwich will now has a disconnected fluidic flow 
addressing to each of them. This allows different drugs and concentrations to be 
added to different units. To further improve the processing capability of the 
platform, RoboTox was also designed according to the standard 96-well plate 
dimensions so that it can be incorporated into commercial robotic liquid handler 
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platform. To demonstrate the RoboTox platform’s high throughput capability, 
IC50 of 6 hepatotoxicants were evaluated. We found that the RoboTox-cultured 
hepatocytes displayed higher sensitivity towards all 6 hepatotoxicants (Table 7, 
Figure 10) probably due to the improved activity of drug metabolism enzymes 
as shown earlier. 
Transition of tissue engineering discovery from laboratory to industry, 
either for therapeutics or pharmaceutical screening, is challenging. With so 
much efforts focusing on the biological or materials aspects, many discoveries 
do not address the downstream technical issues such as cost, usability, 
scalability and manufacturability for industry uses [133]. Such situation is also 
partly due to the traditional research paradigm that assumes transition from 
discovery to usability to manufacturing scalability is linear and sequential [134], 
where scientists focus on fundamental researches while engineers focus on 
product and process development. However, tissue engineering products are 
extremely sensitive to changes, making subsequent modifications to improve 
scalability or usability extremely difficult if not impossible [135, 136]. This 
creates a gap between tissue engineering research and tissue engineering 
products. One approach to overcome the gap is to conduct tissue engineering 
research with specific aim in mind [123, 124] so that research design can be 
guided by having downstream considerations and refinements incorporated into 
the earlier stages of research. The RoboTox platform is an attempt to implement 
this approach: (1) the final use of the in vitro liver culture platform is specified 
at the very beginning of the research, laying down the requirements and 
boundaries for the research. (2) Learning from product development literatures 
[128, 132, 166], special emphasis is placed on translating end user requirements 
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into design guidelines. We have identified 3 important criteria for liver tissue 
culture engineered for drug screening purposes: good hepatocytes differentiated 
functions, robust/ low variability, and high throughput. To recapitulate 
hepatocytes functions, primary hepatocytes were cultured in galactosylated 
Si3N4 sandwich configuration. To minimize variations, collagen gel was 
replaced by microfabricated Si3N4 membrane and perfusion culture was used 
for stable maintenance of cell functions. To enable high-throughput drug 
screening, the bioreactor was designed specifically to decouple the perfusion 
culture flow and drug delivery flow in order to meet the different high 
throughput requirements of the culture stage and the drug testing stage. The 
platform was also designed according to the standard multi-well culture plate 
dimension to incorporate robotic liquid handler for large scale drug testing. (3) 
The bioreactor optimizations, cell function validations and drug testing were 
conducted in a format closely resembling the final form. This enables smoother 
transition from research to industry once all characterizations and process 
optimization are completed.  
4.5 Conclusion 
We have developed a robust and high throughput drug-induced 
hepatotoxicity screening platform using perfusion sandwich-cultured 
hepatocytes. The platform minimized variation by replacing collagen gel with 
galactosylated microfabricated membrane; and by maintaining hepatocyte 
functions with perfusion culture. High-throughput testing was enabled by 
having flow-decoupling and 96-well plate compliant designs that allow 
incorporation of robotic liquid handler. The platform has shown promising 
results for robustness in terms of effective mass transfer, and uniformity of mass 
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transfer as well as cell viability. We have also demonstrated high throughput 
capacity by conducting IC50 test using robotic liquid handler. Coupled with our 
previous results of high hepatocytes differentiated function, high sensitivity and 
low variation in drug testing over different days, we have shown that the 




5 Mechanically optimized Si3N4 membrane for sandwich-
constrained spheroids culture model 
5.1 Introduction 
In the previous chapter, we have demonstrated a robust and high 
throughput hepatotoxicity drug testing platform that utilized a carefully 
designed perfusion bioreactor and silicon nitride sandwich culture 
configurations. The silicon nitride sandwich culture configurations consists of 
a galactosylated PET membrane and galactosylated silicon nitride membrane. 
In our previous work, the morphology of hepatocytes sandwiched between the 
two membranes were not carefully studied. Although the membranes were 
modified with galactose ligands, which has shown to induce hepatocytes to form 
tissue like spheroids spontaneously [167], the hepatocytes were directly in 
contact with stiff silicon nitride membrane. It is well know that hepatocytes 
spheroids are very sensitive to mechanical cues surrounding it [168] , thus 
preformed spheroids can spontaneously spread out and form monolayer when 
transfer to stiff surface [169]. This prompted us to investigate whether the 
hepatocytes cultured in Si3N4 sandwich configuration still maintain their 
spheroids morphology.  
We are interested in creating a sandwich constrained spheroids model 
because despite hepatocytes spheroids’ improved differentiated function, it is 
rarely used in drug testing due to complexity in downstream handling of 
spheroids. The most common spheroids formation methods such as suspension 
culture [72], rotational/rocking culture [69] or hanging drop [170]create floating 
loose spheroids which are difficult to handle in big batches. Hepatocytes formed 
on chemically modified [79] or microfabricated [81] surfaces typically exhibit 
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very low attachment to the surface, thus cell loss is a big issues which introduces 
variation into downstream drug testing results. Hydrogel or scaffold [171, 172] 
are also commonly used to culture hepatocytes spheroids. But their bulk 
structures pose absorption and detection issues in drug testing.  
In our current approach, we plan to create a sandwich constrained 
spheroids model that is able to trap spheroids between two thin membranes. 
Drawing from our previous experience of developing silicon nitride hepatocytes 
sandwich culture model [116], we will first form spheroids on galactosylated 
PET membrane and then trap them with silicon nitride membrane. The 
microfabricated silicon nitride membrane is ultrathin, mechanically and 
chemically stable, and with customizable pores. However, silicon nitride 
membrane is also known to have high stiffness [173] where cells tend to attach 
and spread. We plan to shield the hepatocyte spheroids from the high stiffness 
of silicon nitride membrane with a thin layer of hydrogel. The morphology of 
hepatocytes in such configurations will be studied and its effect on hepatocytes 
synthetic functions, hepatocytes transporter expression, metabolic activities, 
and drug-drug interactions testing will be investigated. 
5.2 Materials and Methods 
5.2.1 Materials 
100 μm thick biaxially oriented polyethylene terephthalate (PET) films 
were purchased from Goodfellow Inc. (Cambridge, UK). The galactose ligand, 
1-O-(6’-aminohexyl)-D-galactopyranoside (AHG, M.W. 279) was synthesized 
as described previously [79, 141] and verified by NMR spectrum. All other 
chemicals were purchased from Sigma-Aldrich (Singapore) unless otherwise 
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stated. Low stress porous Si3N4 membrane was designed, fabricated, surface 
functionalized and characterized as described previously [116, 142] 
5.2.2 Fabrication of Gal-PET, SiN-Gal and SiN-PEG-Gal  
Gal-PET and SiN-Gal was fabricated as previously described [1, 75, 
116]. To fabricate SiN-PEG-Gal, porous Si3N4 membrane was first cleaned with 
piranha solution at 120˚C for 30 min, rinsed with DI water and dried in 100% 
ethanol. PEG was conjugated using Silane-PEG-COOH, MW 5000 (Nanocs Inc, 
USA) by submerging the cleaned glass coverslip in 2mM Silane-PEG-COOH 
solution, freshly prepared with 95% ethanol, for 24 hours.  The PEG-COOH 
surface was then activated by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) and N-Hydroxysuccinimide (NHS) chemistry for 1 hour.  2 mg/ml AHG 
solution in 0.1 M phosphate buffer was then added to the glass coverslip and 
incubated for 48 hours. All components were sterilized by submerging in 70% 
ethanol for 2 hours and rinsed with sterile phosphate buffer saline.  
5.2.3 Rat hepatocyte isolation and culture  
Primary rat hepatocytes were harvested from male Wistar rat weighing 
250-300 g by a modified two-step in situ collagenase perfusion method [28]. 
Animals were handled according to the Institutional Animal Care and Use 
Committee (IACUC) protocol approved by the IACUC of the National 
University of Singapore. Freshly isolated hepatocytes were seeded onto 
collagen-coated 96-well plate or Gal-PET at 1×105 cells/cm2. The cells were 
cultured in William’s E medium supplemented with 1 mg/ml BSA, 10 ng/ml 
EGF, 0.5 μg/ml insulin, 5 nM dexamethasone, 50 ng/ml linoleic acid, 100 
units/ml pencillin and 100 μg/ml streptomycin; and incubated with 37˚C, 5% 
CO2, 95% humidity. Collagen sandwich was assembled by placing a collagen-
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coated polycarbonate membrane (Isopore™, Milipore, USA) on top of the 
hepatocytes seeded on collagen-coated PET film. Si3N4 sandwich culture was 
assembled by placing modified Si3N4 membrane (20 μm pore size and 20 μm 
inter-pore distance, corresponding to 20% porosity) on top of the cells on 
galactose-immobilized PET films. 
5.2.4 X-ray photoelectron spectroscopy (XPS) measurements 
XPS was used to qualitatively verify PEG and galactose conjugation 
onto glass coverslip.  Measurements were made on a VG ESCALAB Mk II 
spectrometer with MgKa X-ray source (1253.6 eV photons) at a constant retard 
ratio of 40. High resolution spectra were collected for C and N elements. 
5.2.5 Scanning electron microscopy (SEM) 
The top and cross section view of the Si3N4 membrane was imaged using 
SEM (JEOL JSM-5600) at 10 kV. The top section was captured with 200X 
magnification while the cross section was captured with 2000X magnification. 
Prior to imaging, dried Si3N4 membrane was sputter-coated with platinum for 
60 s.  
5.2.6 Immunofluorescence microscopy 
Rat hepatocytes were cultured for the desired period before fixing with 
3.7% paraformaldehyde for 15 min. The cells were then permeabelized with 0.5% 
Triton-X for 30 min and blocked with 1% BSA in PBS for 1 hour. To stain F-
actin, cells were incubated in 5 unit/mL AlexaFluor® 488 Phalloidin 
(Invitrogen, USA) in 1% BSA, PBS for 1 hour.  
5.2.7 Cell loss assay 
After 3 days or 5 days of culture, hepatocytes were lysed with Buffer 
RLT Plus (Qiagen, Netherlands) and their DNA quantity was quantified using 
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Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen, USA) according to 
manufacturer’s protocol.  
5.2.8 Urea and albumin synthesis measurement 
Culture media were collected for urea and albumin synthesis 
measurements. Urea content in the culture media was measured using Urea 
Nitrogen Kit (Stanbio Laboratory, USA). Albumin concentration was measured 
using Rat Albumin ELISA Quantification Kit (Bethyl Laboratories Inc., USA). 
The absolute urea and albumin amounts were calculated based on media volume 
that was normalized against the cell number by the end of culture.  
5.2.9 Quantitative polymerase chain reaction (qPCR) measurement 
RNA was isolated using RNeasy Plus Micro Kit (Qiagen, Netherland) 
and converted into cDNA using High Capacity RNA-to-cDNA Kit (Applied 
Biosystem, USA) according to manufacturers’ instruction.  Primers sequences 
for Cyp1a2, Cyp2b1/2, Cyp3a2, and Cyp2c11 are shown in Table 8. qPCR was 
performed using Fast Start Universal SYBR Green Master (Rox) (Roche, 
Switzerland) with 10 ng of cDNA sample on ABI 7500 Fast Real-Time PCR 
system (Applied Biosystem USA). Gene expression was calculated using ∆∆CT 
method normalized to GAPDH.  
Table 8. Primer sequences used for qPCR measurement 





























5.2.10 CYPs induction studies 
On day 3, hepatocyte cultures on different substratum were treated with 
respective CYPs inducers, that is, 40 μM β-naphthoflavone (BNF) for CYP1A2 
and 1 mM phenobarbital (PB) for CYP2B1/2. Dimethyl sulfoxide (DMSO) was 
used to dissolve the inducers to prepare stock solution and its final concentration 
in the culture medium for cell treatment was lower than 0.1%. The culture 
medium with inducers was replenished every 24 hours for a total 48 hours of 
treatment. For CYP activity analysis, probe substrates for each CYP (200 μM 
phenacetin for CYP1A2 and 5 μM midazolam for CYP2B1/2) diluted in Krebs-
Henseleit-bicarbonate (KHB) buffer were incubated with the cell cultures for 
90min and formation of the marker metabolites were determined by liquid 
chromatography-mass spectrometry (LC-MS) method. Cells after probe 
substrate treatment were lysed to measure DNA amounts for cell number 
normalization of the activity data.  
5.2.11 Liquid chromatography- mass spectrometry (LC-MS) 
measurement of CYPs specific activity 
Samples containing metabolites were collected and stored at -80°C until 
LC-MS measurement. To conduct the LC-MS measurement, 50 ul of 100 ng/ml 
internal standard were added to the samples and the mixture were dried using 
Techne® Sample Concentrator (Techne, UK). The dried residues were 
reconstituted using 100 ul of methanol containing 0.1% formic acid. The 
supernatant were then analysed using LC-MS system (LC: 1100 series, Agilent, 
68 
 
US; MS: LCQ Deca XP Max, Termo Finnigan, US) with 100 x 3.0 mm onyx-
monolithic C18 column (Phenomenax, USA) as reported previously [174]. 
5.3 Results 
5.3.1 Modification of Si3N4 membrane with polyethylene glycol layer 
We tried to introduce polyethylene glycol (PEG) as soft buffer between 
Si3N4 membrane and hepatocytes spheroids. 2 different modification 
approaches (1-step conjugation using Silane-PEG-COOH, and 2-steps 
conjugation using NHS-PEG-COOH) were tested (Figure 11).  
 
Figure 11. Surface modification scheme for linking PEG onto silicon nitride 
membrane 
 
XPS was used to detect O1s peak of PEG, chemical formula H-(O-CH2-
CH2)n-OH, and COOH(Figure 12). Our result shows that PEG linking efficiency 
between the 2 methods are quite similar, with the efficiency of 1-step 
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conjugation being slightly higher. Since both 1-step and 2-step PEG conjugation 
methods work equally well for PEG conjugation, the 1-step PEG conjugation 
method was used for its higher conjugation efficiency and shorter processing 
time in our subsequent studies. 
 
Figure 12. XPS scanning for O1s peak as an indicator of PEG conjugation. 
 
To ensure that the PEG hydrogel doesn’t block the pores of Si3N4 
membrane which is important for effective mass transfer, SEM images was 
taken at 200x magnification ( 
Figure 13). On unmodified Si3N4, the surface is smooth and pristine. In 
comparison, small bumps were observed on the surface of Si3N4 membrane, 
showing aggregates of PEG. The pores of Si3N4 membrane can be clearly 
visualized, indicating no obstruction of the porous structures even with PEG 





















Figure 13. SEM image of PEG-modified Si3N4 shows that PEG modification 
doesn't block the pores of the porous membrane. 
 
5.3.2 Hepatocytes spheroids morphology in improved PEG modified 
Si3N4 membrane 
We traced the hepatocytes spheroids morphology maintenance 
constrained by improved PEG-modified Si3N4 membrane and compared them 
against the hepatocytes on galactose membrane without membrane constraints, 
and hepatocytes on galactose membrane constrained by non-PEG modified 
membrane (Figure 14). For hepatocytes cultured on galactose membrane 
without constraining membrane, hepatocytes formed spheroids-like 
multicellular layer on Day 2 and spheroids were formed on Day 3 as reported 
previously [76].  They maintained the spheroids morphology until Day 5. 
However, lesser spheroids were observed by Day 5 on non-constrained 
hepatocytes spheroids culture.  
Hepatocytes cultured on galactose membrane constrained by non-PEG 
modified membrane did not maintain their spheroids morphology during the 
same period despite the presence of galactose ligands. This is probably due to 
the presence of stiff surface from non-PEG modified silicon nitride membrane. 
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Stiff substrate has shown to promote strong cell-substrate interaction which will 
override the cell-cell interaction needed for spheroids formations [168].  In 
contrast, hepatocytes cultured on galactose membrane constrained by PEG-
modified silicon nitride membrane preserved the spheroids morphology like 
those cultured without the overlaying membrane. They formed spheroids-like 
multicellular layer on Day 2 and then morphed into spheroids on Day 3, which 
is similar to hepatocytes on galactose membrane without constraints. More 
importantly, the hepatocytes cultured in this sandwich constrained model seem 
to be able to trap the spheroids by Day 5.   
 
Figure 14. Hepatocytes morphology on different culture configuration from 
Day 2 to Day 5. Scale bar: 100µm.  
 
The cytoskeleton structure of the hepatocytes was investigated by 
staining F-actin with fluorescent-phalloidin (Figure 15). Hepatocytes 
constrained by non-PEG modified Si3N4 membrane spread out, showed cake 
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like structure and exhibited extensive stress fibers formation at the Si3N4 facing 
layers as indicated by white arrows. In comparisons, hepatocytes constrained by 
PEG/Galactose-modified Si3N4 membrane maintained their spheroids 
morphology and exhibited tissue-like cytoskeleton structures throughout 
spheroids. This shows that PEG modification of silicon nitride is crucial for 
hepatocyte spheroids morphology maintenance. 
 
Figure 15. F-actin staining on Day 4 for hepatocytes trapped in galactose-
modified Si3N4 (original configuration) and PEG/galactose-modified Si3N4 




5.3.3 Spheroids-constraining efficiency by silicon nitride membrane 
Since one of the main reasons to develop sandwich-constrained 
spheroids model is to stabilize spheroids cell count in culture system, we 
proceeded to evaluate the spheroids-constraining efficiency of the 
configurations. The spheroids-constraining efficiency was quantified by 
measuring the number of remaining cells in the unconstrained spheroids culture 
and the constrained spheroids culture on Day 3 and Day 5. Day 3 and Day 5 
was selected as the assay time point because previous data [75] shows that 
spheroids formed on galactose-modified PET experienced tremendous cell loss 
between Day 3 and Day 5. The cell number quantification assay was conducted 
by lysing the cells with 0.1% SDS. The cell lysate was then analyzed using 
Picogreen assay that measure total DNA in the solution.  
Our result (Figure 16) shows that cell count dropped tremendously from 
Day 3 (~40,000 cells) to Day 5 (~20,000 cells), which accounts for 48% cell 
lost, in unconstrained spheroids culture.  To trap the spheroids at the bottom of 
the well, we first tried to overlay the spheroids with 4 mm silicon nitride 
membrane. 4 mm was chosen because it corresponds to the size of the bottom 
substrate (galactose-modified PET membrane), and is comparatively easier to 
handle in the 96-well plate (which has a well diameter of 6 mm). However, our 
cell count studies shows that the constraining efficiency of the 4 mm silicon 
nitride membrane was not significantly better as the cell count still dropped 
from ~35,000 cells on Day 3 to ~20,000 cells on Day 5, i.e 39% cell lost. In 
comparison, when the spheroids were trapped by 6mm silicon nitride membrane, 
74 
 
the cell count only drop mildly from ~32,000 cells on Day 3 to ~28,000 cells on 
Day 5, which accounts for only 13% lost in cells number. 
 
Figure 16. Quantification of cell loss in constrained and unconstrained 
spheroids. Data plotted are the mean ± s.e.m of 3 independent experiments. 
 
5.3.4 Hepatocytes synthetic function in improved Si3N4 sandwich culture 
We investigated the effects of improved spheroids morphology 
maintenance on the two main hepatocytes synthetic functions, ie. Urea synthesis 
and albumin synthesis. We found that the urea secretion between the original 
and improved configurations are very similar, with hepatocytes constrained by 
non-PEG modified Si3N4 membrane (original configurations) secreting 
80.27±10.17 µg, 80.51±4.69 µg, 79.09±4.69 µg and 51.89±10.98 µg of 
urea/millions cells/day from Day 2 to Day 5 respectively. Hepatocytes 
constrained by PEG modified Si3N4 membrane (improved configurations) 
secreted 73.49±12.43 µg, 90.13±4.38 µg, 86.77±4.47 µg, and 53.34±5.79 µg of 
urea/million cells/day from Day 2 to Day 5. The p-value of Student t-test were 





Figure 17. Urea synthesis function of hepatocytes cultured in original vs 
improved configurations. Data plotted are the mean ± s.e.m of 3 independent 
experiments. 
 
On the other hand, albumin synthesis function was slightly improved in 
the hepatocytes spheroids constrained by PEG-modified Si3N4 membrane 
(improved configuration) compared to hepatocytes spheroids constrained by 
non-PEG modified Si3N4 membrane (original configuration). The amount of 
albumin synthesized by hepatocytes spheroids cultured in improved 
configurations were 27.84±2.97 µg, 39.39±3.00 µg, 63.26±11.82 µg and 
59.04±6.19 µg respectively from Day 2 to Day 5, compared to 22.33±2.36 µg, 
29.00±2.57 µg, 37.83±6.16 µg and 49.07±8.43 µg of albumin/million cells/day 
synthesize by hepatocytes cultured in original configurations. The p-value for 




Figure 18. Albumin synthesis function of hepatocytes cultured in original vs 
improved configurations. Data plotted are the mean ± s.e.m of 3 independent 
experiments. 
 
5.3.5 Higher transporter RNA expression in improved Si3N4 sandwich 
culture 
Since hepatocytes spheroids has shown to improve transporter 
expression [68, 69], we would like to investigate whether the improved 
spheroids morphology maintenance for hepatocytes constrained by 
Galactose/PEG-modified Si3N4 membrane will also improve transporter 
expression compared to original configurations. qPCR was conducted on the 
gene expression of transporters commonly involved in drug trafficking such as 
bile salt export pump (BSEP), multidrug resistance transporter (MDR1a, 
MDR1b), multidrug resistance-related protein (MRP2, MRP3), Na+-
taurocholate cotransporting polypeptide (NTCP), organic anion-transporting 
polypeptide (OATP1,OATP2). We found that apart from MRP3 and NTCP, the 
gene expression of transporters shows at least 1.5 times increase in the 




Figure 19. Relative RNA expression for hepatocytes cultured in improved 
configurations vs original configurations. Data plotted are the mean ± s.e.m of 
3 independent experiments. 
 


















Fold increase in transporter expression in improved configuration over original configurations
 
Figure 20. Fold increase in transporter RNA expression for hepatocytes 
cultured in improved configurations compared to original configurations. Data 




5.3.6 Higher CYP1A2 and CYP3A2 basal and induced activities in 
improved Si3N4 sandwich culture 
Since our main aim of developing sandwich-constrained spheroids 
culture is to conduct drug testing, the CYPs metabolic function is very important 
to us. Thus, we tested both the basal and induced CYP1A2 and CYP3A2 
activities of hepatocytes cultured in the improved configurations vs the original 
configurations. We found that the basal CYP1A2 activity in hepatocytes 
spheroids cultured in the improved configurations was significantly higher than 
basal CYP1A2 activity in hepatocytes cultured in the original configurations, 
with 86.64±6.93 ng metabolite/million cells detected in 90 min. In comparison, 
only 65.31±4.66 ng metabolite/million cells/90 min were detected in 
hepatocytes cultured in original configurations. The differences is significant 
with p-value of 0.032. Hepatocytes cultured in the improved configurations also 
shows higher amount of induced CYP1A2 activity, with 1340.05±72.74 
ng/million cells/90min while hepatocytes cultured in original configurations 
only generate 1127.82±37.44 ng/million cells/90min. The differences is also 
significant with p-value of 0.026 (Figure 21). 
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Figure 21. CYP1A2 activity of hepatocytes spheroids in improved 
configuration vs original configuration. Data plotted are the mean ± s.e.m of 3 
independent experiments. 
 
Hepatocytes cultured in improved configuration also shows higher basal 
CYP3A2 activity. There were 17.98±2.39 ng/million cells/90 min metabolite 
generated by hepatocytes cultured in improved configurations while 
hepatocytes cultured in the original configurations only generated 11.34±0.85 
ng/million cells/90 mins metabolite (p value=0.031). The induced CYP3A2 
activity was also higher in hepatocytes cultured in the improved configurations, 
with 273.58±32.91 ng/million cells/90 min metabolites detected vs only 
112.30±18.55 ng/million cells/90 min metabolites detected in hepatocytes 
cultured in original configurations (p value=0.005, Figure 22).  
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Figure 22. CYP3A2 activity of hepatocytes spheroids in improved 




In this study, we created a sandwich-constrained spheroids culture 
model. This model is valuable because it is able to overcome cell lost issues 
(Figure 16) that impedes a lot of other hepatocytes cell culture model for 
downstream drug testing. The top membrane is fabricated with ultrathin silicon 
nitride which has previously shown to allow efficient mass transfer [1, 116]. To 
create a soft layer, we grafted a thin layer of PEG hydrogel onto the surface of 
silicon nitride membrane. It has been shows that the maximum thickness of PEG 
films being grafted on surface depends on the length of the polymer chains being 
grafted [175]. Thus by modifying Si3N4 membrane using PEG with fixed 
molecular weight of 5000 MW, which corresponds to 133 units of PEG 
monomers, we can limit the PEG film to less than 10 nm thick [175] and 
minimize bulk absorption. In fact, our SEM images (Figure 13) show that the 
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pores are not blocked at all with current modification, thereby allowing the top 
silicon nitride membrane to maintain its high mass transfer properties.  
Mechanical studies of hepatocytes spheroids have shown that the 
hepatocytes aggregate morphogenesis depends on the interplay of cell-cell 
interactions and cell-substratum interactions – hepatocytes tends to aggregate 
together when cell-substratum interactions are weak while adopt a spread out 
morphology when cell-substratum interactions are strong [176] [177]. There are 
many factors that determine the force of cell-substratum interactions such as 
chemical interactions [177] [16], biological interactions [178], surface rigidity 
[168, 179], surface roughness [180], surface topography [67] etc. In our work, 
hepatocytes spheroids were formed by manipulations of biological interactions 
and surface rigidity. Both our top and bottom membrane were conjugated with 
galactose ligands, which has been shown to induce hepatocytes spheroids 
formation via galactose-asialoglycoprotein receptor (ASGPR) interactions [78]. 
The formation and maintenance of spheroids were also aided by soft surface via 
the presence of polyacrylic acid at the bottom membrane and polyethylene 
glycol at the top membrane. The presence of both soft hydrogel and galactose 
ligands are crucial in maintaining hepatocytes spheroids morphology (Figure 14 
and Appendix Figure 56) 
Our results show that the improved spheroids morphology generally 
improved hepatocytes differentiated functions, which is not surprising given it 
has been reported that stress fibers formation indicates over-stretching and 
spreading of cells, which is detrimental to hepatocytes differentiated functions 
[137]. Urea and albumin synthesis, although not crucial in drug testing, is a 
reliable indicator of hepatocytes differentiation maintenance in vitro. We found 
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that the improved hepatocytes spheroids morphology without the stress fibres 
formation contributes to better albumin synthesis functions (Figure 18).  
We also investigated hepatocytes transporter RNA expression as it has 
been reported that hepatocyte spheroids generally display better structural and 
functional polarity with various biliary transporter expressed[19], probably due 
to better cell-cell interactions. We conducted qPCR on the few important 
transporters that affect drug absorption and disposition such as BSEP, MDR, 
MRP, NTCP and OATP [40, 41]. We found that the improved spheroids 
morphology leads to increase of RNA expression in 6 out of the 8 transporters 
tested (Figure 19). Nevertheless, to indicate proper transporters’ formations and 
functions, more testing such as immunofluorescence staining and specific 
transporter substrate trafficking assays are required.  
Finally, we tested the CYPs activities, which is the most crucial function 
of hepatocytes for in vitro drug testing. We focused on CYP1A2 and CYP3A2, 
which are rat homologues that correspond to CYP1A2 and CYP3A4 in human, 
because they are the two most abundant CYPs found in human liver, which 
respectively constitute 13% and 30% of the total CYP in human liver [31, 35, 
41]. We found that hepatocytes in improved configurations significantly 
improved the basal CYP1A2 and CYP3A2 activities (Figure 21, Figure 22). We 
also found that the hepatocytes in improved configurations has higher induced 
CYP1A2 and CYP3A2 activities, implying they probably maintain better 
expression of transcriptional factors, such as aryl hydrocarbon receptor, 
pregnane X receptor and androstane receptor, required in the induction 




We have optimized the sandwich-constrained spheroids culture model by 
introducing a soft hydrogel on to the surface of Si3N4 membrane. We have 
demonstrated that addition of the soft layer is able to prevent the spreading of 
hepatocytes thus preserving the hepatocytes spheroids morphology. We showed 
that maintenance of hepatocytes spheroids morphology led to improved 
hepatocytes albumin synthesis, improved drug transporter RNA expression, and 
higher CYP1A2 and CYP3A2 basal activities. We demonstrated the usability 
of the system to conduct drug induction studies where the mechanically-
improved sandwich constrained spheroids model showed its capacity to be 
induced to higher CYP1A2 and CYP3A2 activities than hepatocytes cultured in 
original configurations. This demonstrated that the mechanically-improved 
sandwich constrained spheroids culture model is better developed for drug 





6 Perfusion-cultured sandwich-constrained hepatocyte 
spheroids model 
6.1 Introduction 
There are very few drug testing studies using hepatocyte spheroids due 
to handling complexity arising from floating loose spheroids culture on 
rotational culture, non-adhesive surface or ligand-modified film [70, 182]. 
Sponge or gel-like materials, such as polyurethane foams [183, 184] and 
polymeric scaffolds [185] can limit spheroids sizes and are compatible with 
well-plate format but often suffer from the problem of drug absorption to the 
scaffold materials of bulky structures. Microfabricated substrates such as 
microwells [67, 186] or ligand-linked thin films [79] conforms to well-plate 
format and offer minimal absorption, but spheroids in these platforms tend to 
detach from the surface easily. Previously, various groups [77-79, 91, 106] 
including ours [75, 76, 174] have developed galactosylated thin film for 
hepatocytes spheroids culture. This method allows hepatocyte spheroid 
formation on the surface of the thin film placed at the bottom of well plate, 
thereby preventing drug absorption from bulky materials. However, hepatocyte 
spheroids also detach easily from the galactosylated surface, causing variation 
in drug testing results. Attempts have been made to create more stable 
attachment by including RGD ligands [75, 146, 174] and nanofibers [180]. 
These inclusion induce hepatocytes spheroids to spread at the cell-substrate 
contact layers, which compromise certain hepatocyte differentiated functions in 
specific applications [137]. We report here a novel strategy to immobilize 
spheroids on multi-well plates without compromising cell functions or other 
operational characteristics for high throughput applications. 
85 
 
The multicellular structures of spheroids also serve as a diffusion barrier 
for efficient exchange of nutrients, oxygen, drugs and metabolic wastes. It is 
crucial to limit the size and thickness of spheroids to avoid cell necrosis due to 
hypoxia or mal-nutrition in spheroid interior [72]. It is also possible to improve 
the nutrient and oxygen access by subjecting spheroids to perfusion culture. 
Perfusion culture can improve viability, life span and metabolic performance of 
primary hepatocytes [47] due to constant replacement of nutrients and continual 
removal of waste [182]. However, perfusion flow also introduce shear stress 
which is detrimental to hepatocyte function [187]. Some perfusion culture 
models encapsulate hepatocytes spheroids in microsphere [90], or scaffold [91] 
before subjecting them to perfusion flow to protect them from shear stress. Yet, 
they typically do not take downstream drug testing into account. For example, 
loose spheroids in bioreactor makes quantification for drug testing difficult 
while scaffold based bioreactors face drug absorption problems.  
In this study, we attempt to stabilize the spheroids size and cell counts, 
as well as protecting them from perfusion shear stress, by creating a sandwich-
constrained spheroids model where hepatocytes spheroids were trapped 
between a bottom substrate and a microfabricated ultra-thin porous membrane. 
Microfabricated membrane can be made thinner with customizable pores, which 
facilitates improved mass transfer [116]. Previously, we have fabricated such 
membrane using silicon nitride [116]. Although silicon nitride has good 
chemical inertness, high fracture toughness and high wear resistance; it is also 
very brittle and sensitive to stress-induced damage [142, 154, 155]. It has been 
difficult to fabricate membranes covering large area, which is crucial in 
maintain spheroids count as show in Figure 16. Here we replaced silicon nitride 
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membrane with Parylene C membrane. Parylene C is a FDA Class IV approved 
biocompatible materials which is widely used to coat medical implants [188, 
189]. The all-carbon structural backbone, high-MW, and nonpolar entities make 
parylene-C highly resistant to most chemicals [190] This two attributes makes 
it a good cell culture candidates not just only for supporting hepatocytes growth 
but more importantly, minimize the interference with downstream drug testing. 
Moreover, crystalline Parylene C is optically transparent with visible light [191] 
which enable microscopic observation and image-based drug screening 
experiments. Compared to conventional polymeric materials, parylene C is 
unique in terms that it is depositable using by chemical vapour deposition (CVD) 
which forms pinhole free thin layers with controllable thickness of few hundred 
nm up tens of µm[192]; It is machinable using MEMS fabrication [193-195] 
and modifiable with oxygen plasma for ligand conjugation [121]. These 
attributes makes it highly customizable for various cell culture purposes. 
Compared to conventional MEMS materials such as silicon and glass, Parylene 
C is flexible and has high malleability that can withstand up to 200% elongation 
[196]. It is less likely to fracture under physical forces thus is able to constrain 
the spheroids more effectively. 
The sandwich-constrained spheroids culture cassette is designed to be 
transferable between perfusion bioreactors and multi-well plates for high 
throughput applications. 
6.2 Materials and Methods 
6.2.1 Materials 
10 mm diameter glass coverslips were purchased from Paul Marienfeld 
GmbH & Co.KG (Lauda-Königshofen, Germany). Silane-PEG-COOH, MW 
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5000 was purchased from Nanocs Inc. (New York, USA). The galactose ligand, 
1-O-(6’-aminohexyl)-D-galactopyranoside (AHG, M.W. 279) was synthesized 
as described previously [79, 141] and verified by NMR spectrum. Other 
chemicals were purchased from Sigma-Aldrich (Singapore) unless otherwise 
stated.   
6.2.2 Fabrication of PET-poly(Acrylic Acid)-AHG and Glass-PEG-AHG 
(MW5000) 
PET-PAA-AHG was fabricated as previously described [75]. 10 mm 
glass coverslip was cleaned with piranha solution at 120˚C for 30 min, rinsed 
with DI water and dried in 100% ethanol. PEG was conjugated using Silane-
PEG-COOH, MW 5000 (Nanocs Inc, USA) by submerging the cleaned glass 
coverslip in 2 mM Silane-PEG-COOH solution, freshly prepared with 95% 
ethanol, for 24 hours.  The PEG-COOH surface was then activated by 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-Hydroxysuccinimide 
(NHS) chemistry for 1 hour.  2  mg/ml AHG solution in 0.1M phosphate buffer 
was then added to the glass coverslip and incubated for 48 hours. Both PET-
PAA -AHG and Glass-PEG-AHG was sterilized by submerging in 70% ethanol 
for 2 hours and rinsed with sterile phosphate buffer saline.  
6.2.3 X-ray photoelectron spectroscopy (XPS) measurements 
XPS was used to qualitatively verify PEG and galactose conjugation 
onto glass coverslip.  Measurements were made on a VG ESCALAB Mk II 
spectrometer with MgKa X-ray source (1253.6 eV photons) at a constant retard 
ratio of 40. High resolution spectra were collected for C and N elements. 
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6.2.4  Atomic force microscope (AFM) measurements 
Experiments were conducted at room temperature with a Dimension 
Icon AFM system with a Nanoscope V controller and Nanoscope analysis 
(Bruker, Santa Barbara, CA). Nanomechanical measurements were performed 
using the PeakForce QNM (Quantitative NanoMechanics) mode which is based 
on the Derjaguin–Muller–Toropov (DMT) model on an AFM system under 
ambient conditions. Following a proper calibration procedure, samples were 
scanned using the ScanAsyst-air probe with a nominal radius of 2 nm and a 
nominal spring constant of 0.5 Nm at a scan rate 1Hz. 
Peak-force tapping AFM is an operating mode that can control the 
maximum normal force (“peak force”) applied on the samples at each point of 
the map. Nanoscale property and peak force are obtained by collecting a force 
curve at each pixel. The force–separation curves are subsequently analysed to 
obtain information on sample adhesion, surface deformation and topography. 
Adhesion force is the minimum force depending on the interaction between the 
tip and sample while deformation is the difference of the separation from the 
force equal to zero to the peak force. The reduced elastic modulus E* is obtained 
by fitting the experimental data using the Derjaguin–Muller–Toropov (DMT) 






2 +  𝐹𝑎𝑑ℎ 
where Ftip is the force on the tip, Fadh is the constant adhesion force 
during contact, R is the tip end radius, and d is the tip to sample separation. The 
reduced modulus E* is related to the sample elastic modulus Es by: 













where n and E are the Poisson's ratio and Young's modulus and the 
subscripts “t” and ”s” stand for the tip and sample, respectively. In our materials 
system, the tip modulus, Et, is much larger than Es so that the first term of 
equation (2) can be neglected. Hence, Es is calculated easily given the Poisson's 
ratio ns. 
6.2.5 Rat hepatocyte isolation and culture  
Primary rat hepatocytes were harvested from male Wistar rat weighing 
250-300 g by a modified two-step in situ collagenase perfusion method [28]. 
Animals were handled according to the Institutional Animal Care and Use 
Committee (IACUC) protocol approved by the IACUC of the National 
University of Singapore. Freshly isolated hepatocytes were seeded onto 
collagen-coated 48-well plate or PEG-galactose modified glass coverslip at 
1×105 cells/cm2. The cells were cultured in William’s E medium supplemented 
with 1 mg/ml BSA, 10 ng/ml EGF, 0.5 μg/ml insulin, 5 nM dexamethasone, 50 
ng/ml linoleic acid, 100 units/ml pencillin and 100 μg/ml streptomycin; and 
incubated with 37˚C, 5% CO2, 95% humidity. 
6.2.6 Live imaging of spheroids formation  
 The dynamics of rat hepatocyte formation were captured in bright field 
image at 10X magnification using Cell-IQ® MLF (CM Technologies, Finland). 
The rat hepatocytes were allowed to attach for 2 hours prior to imaging to 
minimize disturbance of plate repositioning to the cells. The built-in incubation 
chamber was maintained at 37˚C, 5% CO2. Sterile water was added into empty 
wells to maintain humidity.  
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6.2.7 Quantification of spheroids formation efficiency 
The quantification of spheroids formation efficiency was performed 
based on the decrease of cell coverage areas over time on the notion that when 
spheroids forms, smaller area will be covered by cells. The cell area 
quantification was performed by Cell Analyzer Software equipped with Cell-
IQ® MLF. Briefly, the software applies proprietary algortithms to identify cell-
occupied areas, and calculate the number of positive (cell-occupied) pixels for 
every image. The cell coverage area was then calculated by dividing the number 
of positive pixels by the total number of pixels per image. 
6.2.8 Fabrication of parylene membrane 
4 inch 300 um-thick Si wafers, double polished, <100> crystallographic 
orientation, were cleaned in piranha solution (H2SO4:H2O2, 2:1) at 120˚C for 30 
min. 2 µm thick silicon oxide was grown on silicon surface in furnace (Tystar, 
US) by wet process at 1050°C for 11 hours. The silicon oxide on the top surface 
was patterned with mechanical anchor using photolithography then stripped 
using buffered oxide etch for 35 min while the back of the wafer was protected 
with a layer of photoresist. Mechanical anchor patterning was performed as 
described previously [197], similar to SCREAM process [198], in DRIE 
(Alcatel 100 SE). Briefly, silicon was anisotropic etched using conventional 
Bosch process to create straight trenches (4 µm width, 30 µm depth). This was 
followed by C4F8 passivation process to coat the newly created trenches. The 
passivation layer was then anisotropic etched again so that fresh silicon surface 
was exposed at the bottom of the trench while the wall remained covered by the 
passivation layer. The exposed silicon layer at the bottom was then anisotropic 
etched with SF6 to create “mushroom-like” profile. Parylene C was deposited 
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with Specialty Coating System. The pores on parylene were patterned using 
photolithography with photoresist as mask and etched with oxygen plasma. The 
membranes were then released from silicon wafer with silicon etching.    
6.2.9 Modification of parylene membrane 
Parylene membrane was modified as previously described [121] with 
minor modification. Briefly, the parylene membrane was oxidized by oxygen 
plasma (SAMCO PECVD BP-1) for 30 seconds, at 50 Pa air pressure and 125 
W power. Oxidized parylene membrane was then submerged in 2 mM Silane-
PEG-COOH, 5000 MW in 95% ethanol for 24 hours. The membrane was then 
washed with ethanol and PBS before activation with EDC/NHS chemistry for 1 
hour.  2 mg/ml AHG solution in 0.1 M phosphate buffer was then added to the 
membrane and incubated for 48 hours. Modified parylene membrane was 
sterilized by submerging in 70% ethanol for 2 hours and rinsed with sterile 
phosphate buffer saline.  
6.2.10 Scanning electron microscopy (SEM) 
The top and cross section view of the parylene membrane was imaged 
using SEM (JEOL JSM-5600) at 10 kV. The top section was captured with 
200X magnification while the cross section was captured with 2000X 
magnification. Prior to imaging, dried parylene membrane was sputter-coated 
with platinum for 60 seconds.  
6.2.11  Perfusion-cultured sandwich-constrained spheroids system setup 
The culture system was set up as shown in Figure 23. Primary rat 
hepatocytes were harvested and seeded immediately on bottom substrates. The 
cells were cultured for 24 hours for them to form spheroids before overlaid with 
parylene membrane. The sandwich-constrained spheroids configuration was 
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secured by minusheet tissue carrier (Minucells and Minutissue Vertriebs GmbH, 
Germany). The sandwich-constrained spheroids configuration was then 
transferred to laminar flow bioreactor developed previously [23]. The perfusion 
was conducted in close-loop format consisting of the bioreactor, medium 
reservoir, peristaltic pump (Ismatec SA, Switzerland), stopping valves 
(Upchurch Scientific, USA) and oxygen-permeable silicone tubing (Ismatec SA, 
Switzerland). After the desired culture periods, the bioreactors were 
disassembled and the sandwich-constrained spheroids construct was transfered 





Figure 23. Schematic representation of the setup of perfusion-cultured 




6.2.12 Immunofluorescence microscopy 
Rat hepatocytes were cultured for the desired period before fixing with 
3.7% paraformaldehyde for 15 min. The cells were then permeabelized with 0.5% 
Triton X for 30 min and blocked with 1% BSA in PBS for 1 hour. To stain F-
actin, cells were incubated in 5 unit/mL AlexaFluor® 488 Phalloidin 
(Invitrogen, USA) in 1% BSA, PBS for 1 hour. To stain MRP2, cells were 
incubated in 50 µg/ml rabbit anti-MRP2 (Sigma Aldrich, USA) in 1% BSA, 
PBS in 4°C overnight. The cells were then washed and stained with 40 µg/ml 
AlexaFluor® 533 goat anti-rabbit secondary antibody for 3 hours in the dark. 
Confocal microscopy images were acquired using Olympus Fluoview 300 or 
Olympus Fluoview 1000 confocal microscope (Olympus, Japan).  
6.2.13 Cell loss assay 
After 8 days or 14 days of culture, hepatocytes were lysed with Buffer 
RLT Plus (Qiagen, Netherlands) and their DNA quantity was quantified using 
Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen, USA) according to 
manufacturer’s protocol. Percentage of remaining hepatocytes on culture 
substratum was calculated by normalizing to the DNA amount on day 2 of 
culture.  
6.2.14 Quantitative polymerase chain reaction (qPCR) measurement 
RNA was isolated using RNeasy Plus Micro Kit (Qiagen, Netherland) 
and converted into cDNA using High Capacity RNA-to-cDNA Kit (Applied 
Biosystem, USA) according to manufacturers’ instruction.  Primers sequences 
for Cyp1a2, Cyp2b1/2, Cyp3a2, and Cyp2c11 are shown in Table 8. qPCR was 
performed using Fast Start Universal SYBR Green Master (Rox) (Roche, 
Switzerland) with 10 ng of cDNA sample on ABI 7500 Fast Real-Time PCR 
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system (Applied Biosystem USA). Gene expression was calculated using ∆∆CT 
method normalized to GAPDH.  
 
Table 9. Primer sequences used for qPCR measurement 


























6.2.15 Image processing 
Quantification of MRP2 localization along cell boundaries (F-actin) was 
performed by implementing an image-processing algorithm developed in 
MATLAB R2011a (Mathworks, Massachusetts). The green pixels from the F-
actin staining were first binarized by thresholding segmentation to yield cell 
boundaries. Distance transform was then performed to compute the Euclidean 
distance of each pixel in the image to the boundaries [199]. The red pixels in 
the same image from the MRP2 staining were binarized to yield the regions that 
contained a significant concentration of the respective marker; and the total 
number of red pixels in the image was calculated as Itotal. For each red pixel, the 
distance to the closest cell boundary pixel was obtained from the distance 
transform. Intra-cellular red pixels within a 2-pixel distance from the closest 
boundary pixel were counted as Ilocalized. The ratio between Ilocalized and Itotal was 
used to describe the localization of MRP2 along the cell boundary. 
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For MRP2/CD147 apical-basolateral co-stained samples, XZ and YZ 
dimension were visualized using IMARIS. Colocalization, as represented by 
Manders’ coefficient, were calculated using Just Another Colocalization Plugin 
(JACoP) module [200] in ImageJ.    
6.2.16 Urea and albumin synthesis measurement 
Culture media were collected for urea and albumin synthesis 
measurements. Urea content in the culture media was measured using Urea 
Nitrogen Kit (Stanbio Laboratory, USA). Albumin concentration was measured 
using Rat Albumin ELISA Quantification Kit (Bethyl Laboratories Inc., USA). 
The absolute urea and albumin amounts were calculated based on media volume 
that was normalized against the cell number by the end of culture.  
6.2.17 Liquid chromatography- mass spectrometry (LC-MS) 
measurement of CYP specific activity 
For CYPs specific activity analysis, hepatocytes were cultured for 8 or 
14 days before adding CYP-specific substrates diluted in Krebs-Henseleit 
buffer (KHB) and incubated for 1.5 hours. Hepatocytes in perfusion culture 
were removed from the bioreactor and transferred to multi-well plates for this 
experiment. The samples were collected and stored at -80°C until LC-MS 
measurement. To conduct the LC-MS measurement, 50 ul of 100 ng/ml internal 
standard were added to the samples and the mixture were dried using Techne® 
Sample Concentrator (Techne, UK). The dried residues were reconstituted 
using 100 ul of methanol containing 0.1% formic acid. The supernatants were 
then analysed using LC-MS system (LC: 1100 series, Agilent, US; MS: LCQ 
Deca XP Max, Termo Finnigan, US) with 100 x 3.0 mm onyx-monolithic C18 




6.3.1 Fabrication of Glass-PEG-AHG for rapid hepatocyte spheroid 
formation 
Glass-PEG-AHG was fabricated by sequential conjugation of PEG and 
followed by galactose moiety in the form of 1-O-(6’-aminohexyl)-D-
galactopyranoside (AHG) (Figure 24).  
 
 
Figure 24. Modification schematics of bottom substrate. 
 
The effectiveness of grafting was demonstrated by XPS analysis (Figure 
25). A comparison of high resolution C1s scans between pristine glass coverslip 
and PEG-modified coverslip revealed an increase in C-O (shifted from 1.5eV 
from C-C peaks), indicating successful conjugation of PEG (Figure 25(i) and 
(ii)). More C-H bonds are detected compared to C-O bonds after conjugation of 
galactose (AHG) as it detected the C-H bond from the galactose moiety (Figure 
25(iii)) A high resolution N1s scan revealed an increase of N element after 
conjugation of galactose, compared to pristine glass coverslip and PEG-
modified coverslip, as it detected the N element from 1-O-(6’-aminohexyl)-D-




Figure 25. X-ray Photoelectron Spectroscopy (XPS) analysis of modified 
substrates. 
 
To investigate the topography of the modified surface, we conducted 
height measurement with atomic force microscopy (Figure 26). Glass coverslip 
showed a relatively smooth surface. PEG-modified glass coverslip showed a 





Figure 26. 2D and 3D surface topography images by atomic force microscope 
(AFM). 
We are confident that the glass coverslip was entirely covered by PEG 
because the average stiffness dramatically decreases from 16.4 GPa for glass 
cover slip to 5.2 GPa for PEG-modified glass coverslip (Table 10). We also 
conducted height and stiffness measurement using AFM on PET-PAA-AHG, a 
galactosylated-film for hepatocytes spheroids culture developed previously [76, 
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78, 174]. We found that the surface roughness of PET and PET-PAA are much 
higher than Glass and Glass-PEG, while the stiffness for Glass-PEG and PET-
PAA are in the same magnitude.  
Table 10. Roughness and stiffness measurement using AFM 
 Glass Glass-PEG PET PET-pAAc 
Roughness (Rq) 0.666 nm 0.636 nm 6.22 nm 3.05 nm 
Stiffness 
(Average) 
16.352 GPa 5.245 GPa 2.598 GPa 4.023 GPa 
 
The dynamics of spheroid formation on the Glass-PEG-AHG were 
captured using time-lapsed imaging and compared to spheroid formation on 
PET-PAA-AHG developed previously (Figure 27). Rat hepatocytes migrated to 
form small cell aggregates on Glass-PEG-AHG and PET-PAA-AHG by 6 hours 
after seeding, with higher migratory efficiency observed for rat hepatocytes 
seeded on Glass-PEG-AHG than PET-PAA-AHG. Rat hepatocytes seeded on 
Glass-PEG-AHG continued aggregating together for the next 24 hours, while 
hepatocytes seeded on PET-PAA-AHG were more spread out, forming smaller 
clusters with many of them remaining as single cells. Hepatocytes seeded on 
Glass-PEG-AHG formed distinct spheroids with clear boundaries by 48 hours 
after seeding but hepatocytes seeded on PET-PAA-AHG were more aggregate-
like with some cells scattered around. Rat hepatocytes only formed distinct 




Figure 27. Time-lapse light microscopy imaging of hepatocytes spheroids 
formation. Scale bar: 100µm.  
 
Quantification of spheroid formation efficiency was measured by 
substratum coverage (Figure 28). In the first 24 hours, the area coverage for 
hepatocytes seeded on Glass-PEG-AHG showed steady decline, while area 
coverage for hepatocytes seeded on PET-PAA-AHG remained constant. The 
area coverage for hepatocytes seeded on PET-PAA-AHG only started to show 
decline after 30 hours post seeding. It has been reported previously that PET-
PAA-AHG cultured hepatocytes took up to 72 hours to form spheroids [76]. 
The hepatocytes substratum coverage on PET-PAA-AHG at 72 hours is 46% ± 
13%, thus 46% is used as an indication of spheroid formation. Our results show 
that the substratum coverage for hepatocytes seeded on Glass-PEG-AHG 
decreased rapidly to 46% ± 3% by 30 hours post-seeding, indicating much more 
rapid spheroids formation. There was a significant drop in substratum coverage 
102 
 
for hepatocytes seeded on Glass-PEG-AHG after media change on Day 2, 
indicating low adhesion of hepatocytes after spheroid formation.   
 
 
Figure 28. Quantification of culture areas covered by hepatocytes as spheroids 
formation indication 
 
To find out whether earlier formation of hepatocytes spheroids leads to 
better reestablishment of hepatocytes differentiated function, we conducted 
qPCR on the gene expression of Cyp1a2, Cyp3a2 (Figure 29) and transporters 
Bsep, Mrp2, Oatp1 and Oatp2 (Figure 30). We found that Cyp1a2 and Cyp3a2 
expression on Day 1 were very similar for hepatocytes cultured on PET-PAA-
AHG and Glass-PEG-AHG. However, hepatocytes cultured on Glass-PEG-
AHG started to show higher expression of Cyp1a2 on Day 2. And by Day 3, 
gene expression of Cyp1a2 and Cyp3a2 are 4.03±1.71 and 3.25±2.25 fold 
higher for hepatocytes cultured on Glass-PEG-AHG compared to hepatocytes 




Figure 29. CYPs RNA expression of hepatocytes cultured on PET-PAA-AHG 
vs Glass-PEG-AHG.  
 
The effects of early formation of hepatocytes spheroids on Glass-PEG-
AHG were even more significant on transporter RNA expression. Bsep and 
Oatp2 expressions were significantly higher for hepatocytes cultured on Glass-
PEG-AHG compared to hepatocytes cultured on PET-PAA-AHG from Day 1. 
By Day 2, all four transporters tested showed significantly higher expressions 
which was also observed on Day 3. On Day 3, Bsep RNA expression was 
3.17±0.44 times higher on hepatocytes cultured on Glass-PEG-AHG compared 
to hepatocytes cultured on PET-PAA-AHG;   Mrp2 RNA expression was 
1.46±0.10 times higher; Oatp1 RNA expression was 5.17±0.45 times higher; 




Figure 30. Transporter RNA expression of hepatocytes culture on PET-PAA-
AHG vs Glass-PEG-AHG. 
 
6.3.2 Fabrication and modification of Parylene-PEG-AHG for sandwich-
constrained spheroids 
Parylene membrane was fabricated using micro-electronic-mechanics 
system as shown in Figure 31 and characterized using scanning electron 




Figure 31. Fabrication schematic of parylene membrane. 
 
SEM shows that the polymeric membrane has uniform pores distribution 
and pores size (Figure 32(i)). The thickness of the membrane is around 2.5 um 
(Figure 32(ii)). Due to the thinness and low absorption properties in visible light 
region, the parylene membrane appears to be transparent (Figure 32(iii)). 
 
Figure 32. Scanning electron microscope (SEM) and photograph of parylene 
membrane showing uniform pores size (20µm diameter) and distribution, as 
well as its thin and transparent quality. (i) Scale bar: 100µm (ii) Scale bar: 
10µm.   
 
Mechanical rigidity [168] and ligands presented [106] could affect the 
formation of hepatocyte spheroids. Pre-formed hepatocyte spheroids will 
disintegrate into monolayer when transferred to adhesive ligands such as 
collagen [16]. However, it is not known how the mechanical rigidity and ligands 
of the top membrane would affect the morphology of pre-formed hepatocytes. 
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To investigate whether additional modification is needed for the top membrane 
to preserve hepatocyte morphology in spheroids, the parylene membrane was 
modified with AHG (galactose ligands) or PEG-AHG (soft substrates + 
galactose ligands) and their effects on hepatocyte spheroids formed on Glass-
PEG-AHG were examined (Figure 33). The light microscope images revealed 
that without any modification, the hepatocyte spheroid morphology was 
disrupted, with individual hepatocytes scattered around some aggregates. 
Hepatocyte spheroids overlaid with AHG-modified parylene maintained their 
aggregated form, but with cell spreading observed around the border of the 
spheroids. Only hepatocytes overlaid with parylene membrane modified with 
PEG-AHG maintained their spheroid morphology. The F-actin cytoskeleton 
structures of the hepatocytes spheroids overlaid by different types of parylene 
membrane were also investigated. For hepatocyte spheroids overlaid with 
unmodified parylene membrane, stress fibres in hepatocytes were observed, 
reminiscent of the cells strongly adhering to rigid substrata [201]. Hepatocyte 
spheroids overlaid with AHG-modified parylene membrane showed filapodia-
like structures around the spheroid borders, which correspond to the cell 
spreading observed in the light microscope images. Only hepatocyte spheroids 
overlaid with PEG-AHG modified parylene membrane preserved the cortical F-




Figure 33. Light microscope and F-actin distribution on Day 4. Scale bar: 100 
µm. 
 
We investigated the capability of the parylene membrane in trapping 
spheroids by measuring the cell counts on 8 days and 14 days in static and 
perfusion cultures and comparing them against cell counts measured on Day 2 
(Figure 34). We found that overlaying parylene membrane on top of the 
hepatocytes seeded on Glass-PEG-AHG (sandwich-constrained spheroids/SCS) 
significantly retained hepatocytes cell counts when compared to the 
unconstrained spheroids. Overlaying the parylene membrane also effectively 
preserved the cell numbers in perfusion culture (SCS-Perfusion) as indicated by 
the insignificant differences in cell counts between static-cultured SCS and 
perfusion-cultured (SCS-Perfusion). Overall, the cell counts in the cultured SCS 
and SCS-Perfusion models were maintained at the same level as the cell count 




Figure 34. Hepatocytes spheroids count preservation. 
 
6.3.3 Optimization of the perfusion initiation 
Previously we reported that different perfusion initiation time in 
bioreactors affects cytoskeleton reorganization in collagen sandwich-cultured 
hepatocytes [23]. Specifically, perfusion flow initiated immediately upon 
collagen sandwich assembly on day 1 showed irregular cell morphology, 
disrupted F-actin distribution and disrupted polarities. An extra day of static 
culture was necessary prior to perfusion initiation to preserve the actin filament 
anchorage, tight junction formation and cellular functions. However, since 
hepatocyte spheroids were formed rapidly within 1 day in sandwich-constrained 
assembly, we investigated whether the extra-day of static culture stabilization 




Figure 35. Schematic of experiment timelines for 2 different perfusion culture 
 
We found that the F-actin cytoskeleton structures were not significantly 
altered by perfusion culture whether they were initiated immediately after SCS 
assembly on Day 1 or initiated one day later on Day 2 (Figure 36).  
 
Figure 36. F-actin distribution of hepatocytes spheroids on Day 7. Scale bar: 
50 µm. 
 
Subsequently, we investigated the impact of immediate perfusion 
initiation on the expression of major drug metabolic enzymes (Figure 37). Our 
qPCR measurement of CYPs gene expressions on Day 7 shows that immediate 
initiation of perfusion culture leads to statistically significant higher expression 
of Cyp1a2, Cyp2b1/2, Cyp3a2, and Cyp2c11. The gene expressions of 
hepatocytes where perfusion culture was initiated immediately on Day 1 were 
1.67 ± 0.23 folds higher for Cyp1a2, 2.28 ± 0.57 folds higher for Cyp2b1/2, 
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3.88 ± 1.02 folds higher for Cyp3a2, and 5.95 ± 1.70 folds higher for Cyp2c11 
compared to hepatocytes where perfusion culture was initiated on Day 2.  
 
Figure 37. Fold differences in Day 7 gene expression for perfusion culture 
initiated on Day 1 vs Day 2. Data plotted represents the mean ± s.e.m of 3 
independent experiments using gene expression level of Day 2 as baseline. *: 
p < 0.05. 
 
We also compared the gene expression profile of the perfusion-cultured 
hepatocytes against collagen sandwich-cultured hepatocytes over time.  The 
relative gene expression results of collagen sandwich-cultured hepatocytes on 
Day 7 was indicated as dotted line (Figure 38). We found that the gene 
expression of Cyp1a2, Cyp2b2 and Cyp3a2 of perfusion-cultured hepatocytes 
were significantly higher than collagen sandwich-cultured hepatocytes. 
Remarkably, the gene expression of Cyp3a2 of perfusion-cultured hepatocytes 
was maintained at 76.98% ± 0.18% of those expressed in freshly isolated rat 
hepatocytes. In comparison, collagen sandwich-cultured hepatocytes only 
expressed 3.32% ± 1.6% of Cyp3a2 gene expressed in freshly isolated 
hepatocytes. However, it is also important to note that the expression of 
Cyp2c11 was much lower in perfusion-cultured sandwich constrained spheroids 





Figure 38. Day 7 relative gene expression of SCS-Perfusion cultured 
hepatocytes. Relative gene expression of collagen sandwich is indicated as 
dotted line. Data plotted represents the mean ± s.e.m of 3 independent 
experiments. *: p < 0.05. 
 
6.3.4 Urea and albumin synthesis function of hepatocytes cultured in 
SCS-P model  
Hepatocytes’ urea and albumin synthesis functions in three different 
culture configurations were monitored over 8 days. SCS showed significant 
increase in urea synthesis compared to collagen sandwich model throughout 8 
days of culture (Figure 39). The amount of urea synthesized by collagen 
sandwich cultured hepatocytes on Day 2, 4, 6 and 8 were 67.77 ± 13.52, 57.40 
± 12.29, 38.41 ± 12.50, 24.28 ± 7.30 µg/million cells/day respectively; whereas 
the amount of urea secreted by SCS-cultured hepatocytes on the same period 
were almost 5 times higher at 322.31 ± 82.39, 179.97 ± 28.19, 161.6 ± 27.69 
and 121.62 ± 24.56 µg/ million cells/ day. Urea synthesis capacity of SCS was 
112 
 
furthered enhanced by perfusion culture. The amount of urea secreted by SCS-
Perfusion cultured hepatocytes on Day 2, 4, 6 and 8 were 1752.38 ± 462.48, 
547.87 ± 93.47, 898.06 ± 231.22 and 582.68 ± 134.09 µg/ million cells/ day 
respectively.  
 
Figure 39. Urea secretion of hepatocytes cultured in collagen sandwich, SCS 
and SCS-Perfusion. Data plotted represents the mean ± s.e.m of 3 independent 
experiments. *: p < 0.05. 
 
Albumin secretion seemed lower in SCS and SCS-P compared to 
collagen sandwich culture (Figure 40) even though the differences were not 
significant after student t-test analysis. The albumin secreted by hepatocytes 
cultured in collagen sandwich configuration ranged from 18.51 ± 2.27 µg/ 
million cells/ day to 43.45 ± 16.01 µg/ million cells/ day. In comparison, the 
albumin secreted by hepatocytes cultured in SCS and SCS-Perfusion ranged 
from 11.36 ± 3.148 ~ 25.79 ± 7.55 µg/ million cells/ day and 10.67 ± 6.19 ~ 




Figure 40. Albumin secretion of hepatocytes cultured in collagen sandwich, 
SCS and SCS-perfusion. Data plotted represents the mean ± s.e.m of 3 
independent experiments. N.S: p > 0.05. 
 
6.3.5 Polarity maintenance of hepatocytes cultured in SCS-P model  
Hepatocytes polarity plays crucial roles in xenobiotics uptakes and 
excretion. In order to investigate the maintenance of hepatocytes polarity in our 
model, we used multidrug resistant–associated protein MRP2 localization to the 
apical membrane as an indicator. In polarized hepatocytes, MRP2 localized 
specifically to apical membrane [202]. When hepatocytes lose their polarity, 
MRP2 is internalized and redistributed into intercellular structures [203, 204] 
and nuclear membrane [205].  
In our studies, hepatocytes were stained with F-actin to determine the 
cell boundaries and the subcellular location of MRP2 was identified. We found 
that MRP2 distribution is diffused in cytoplasm in Day 8 collagen sandwich 
cultured hepatocytes while they were slightly more localized to cell boundaries 
in SCS. SCS-P cultured hepatocytes displayed the highest amount of MRP2 




Figure 41. F-actin and MRP2 staining of hepatocytes cultured in collagen 
sandwich, SCS and SCS-perfusion on Day 8. Scale bar: 50 µm.  
 
The image were quantified using image processing algorithm. The cell 
boundaries as indicated by green pixels (F-actin) was binarized. MRP2, 
represented by red pixels, was considered localized if they are within 2-pixel 
distance from green pixel. The localization ratio was calculated based on total 
localized red pixels divided by total red pixel detected. We found that 82.54% 
± 1.58% of MRP2 was localized in perfusion-cultured SCS. This is significantly 
higher than the localization of MRP2 in static-cultured SCS and collagen 
sandwich, where only 65.45% ± 2.44% and 34.68% ± 3.69% of MRP2 were 




Figure 42. Quantification of MRP2 localization along cell boundaries. *: p < 
0.05. 
 
To further confirm MRP2 is located at apical domain, we counterstained 
MRP2 with CD147, a basolateral marker (Figure 43). In Day 8 collagen 
sandwich culture, MRP2 was seen located mainly in the nucleus of hepatocytes, 
indicating improper localization of MRP2 and loss of polarities. In comparison, 
MRP2 was found in segregated regions in SCS and SCS-P cultured hepatocytes 
and was separated from CD147, indicating formation of apical-basolateral 
distinction and maintenance of hepatocytes polarity. We measured the 
MRP2/CD147 colocalization proportion using JACoP module in ImageJ. The 
Manders’ coefficient for collagen sandwich, SCS and SCS-P are 0.598, 0.299 
and 0.262 resepctively. With 0 corresponding to non-overlapping image and 1 
reflecting 100% colocalization, these result suggests that MRP2/apical and 
CD147/basolateral in SCS and SCS-P were more spatially segregated then 




Figure 43. CD147 (green) and MRP2 (red) staining of hepatocytes cultured in 
collagen sandwich, SCS and SCS-Perfusion on Day 8. Scale bar: 20 µm.  
 
6.3.6 Metabolic activity of CYP1A2, CYP2B1/2 and CYP3A2 enzymes of 
hepatocytes cultured in SCS-P model  
 The metabolism activities of CYP1A2, CYP2B1/2 and CYP3A2 
enzymes were measured using their respective specific substrates phenacetine, 
bupropion and midazolam. The quantity of their respective metabolite 
acetaminophen, OH-bupropion and 1’-OH-midazolam were measured with LC-
MS. We found that hepatocytes cultured in spheroids model (either in static or 
in perfusion) shows enhanced CYP1A2 activity; the amount of acetaminophen 
(metabolite of phenacetine metabolized by CYP1A2) produced by SCS-
cultured hepatocytes was measured at 127.09 ± 18.16 ng/million cells/ 90 min, 
while SCS-P cultured hepatocytes produced 99.97  ±  8.57 ng/million cells/ 90 
min on Day 8. This is almost 2 times higher than amount of acetaminophen 
produced by collagen sandwich cultured-hepatocytes on day 8 (52.43 ± 7.48 ng/ 
million cells/ 90 min).  On day 14, the amount of acetaminophen measured in 
SCS and SCS-P cultured hepatocytes were 88.12 ± 8.27 ng/ million cells/ 90 
min and 95.73 ± 10.36 ng/ million cells/ 90 min respectively. In comparison, 
only 26.98 ± 2.60 ng/ million cells/ 90 min of acetaminophen was measured in 




Figure 44. Metabolic activity of CYP1A2 enzymes of hepatocytes cultured in 
collagen sandwich, SCS and SCS-perfusion. Data plotted represents the mean 
± s.e.m of 3 independent experiments. *: p < 0.05. 
 
The CYP2B1/2 activity of hepatocytes was quantified by measuring the 
amount of OH-bupropion metabolized from bupropion. On day 8, the amount 
of OH-bupropion produced by collagen sandwich-cultured hepatocytes was 
8.97 ± 0.67 ng/ million cells/ 90 min, which is similar to SCS-cultured 
hepatocytes which produced 7.45 ± 0.42 ng/ million cells/ 90 min of OH-
bupropion. In comparison, the amount of OH-buproprion produced by SCS-P 
cultured hepatocytes was significantly higher at 17.76 ± 1.34 ng/ million cells/ 
90 min on day 8. On day 14, the amount of OH-bupropion produced by collagen 
sandwich and SCS-cultured hepatocytes were 11.46 ± 1.81 ng/ million cells/ 90 
min and 9.95 ± 2.03 ng/ million cells/ 90 min respectively. The amount of OH-
bupropion produced by SCS-P cultured hepatocytes was slightly higher at 17.31 





Figure 45. Metabolic activity of CYP2B1/2 enzymes of hepatocytes cultured 
in collagen sandwich, SCS and SCS-perfusion. Data plotted represents the 
mean ± s.e.m of 3 independent experiments. *: p < 0.05. 
 
To quantify the activity of CYP3A2, we measured the amount of 1’-OH-
midazolam metabolized by CYP3A2 from midazolam. On day 8, the amount of 
1’-OH-midazolam produced by collagen sandwich and SCS-cultured 
hepatocytes were 10.78 ± 1.43 ng/ million cells/ 90 min and 8.28 ± 1.59 ng/ 
million cells/ 90 min respectively. The amount of 1’- OH midazolam produced 
by SCS-P cultured hepatocytes was significantly higher at 28.74 ±5.98 ng/ 
million cells/ 90 min. On day 14, collagen sandwich and SCS cultured 
hepatocyte produced 7.79 ± 2.39 ng/ million cell/ 90 min and 12.31 ± 3.92 ng/ 
million cell/ 90 min of 1’-OH-midazolam. In comparison, SCS-P cultured 
hepatocytes produced 37.57 ±11.8 ng/ million cells/ 90 min of 1’-OH-




Figure 46. Metabolic activity of CYP3A2 enzymes of hepatocytes cultured in 
collagen sandwich, SCS and SCS-perfusion. Data plotted represents the mean 
± s.e.m of 3 independent experiments. *: p < 0.05. 
 
6.4 Discussion 
Despite the various advantages of spheroids culture in maintaining 
hepatocytes differentiated functions, it is rarely used in drug testing, as the 
spheroids culture platform tends to introduce great variation in drug testing 
procedures. Hepatocytes formed on rotational culture, non-adhesive surface or 
ligand-modified film [70, 182] introduce handling complexity arising from 
floating loose spheroids. Inconsistent spheroid quantities can cause variation in 
drug testing results. Spheroids trapped in scaffold or gel-like materials might 
also impede drug access. In our approach, cell loss is minimized by trapping 
spheroids with an ultra-thin microfabricated porous membrane (Figure 34). The 
thin parylene membrane (1-2 um) (Figure 32(ii)) minimizes drug absorption 
arising from bulky material structures. The membrane has uniform pores that 
allow homogenous access of nutrients and drugs to the cell. Parylene membrane 
is transparent to visible light (Figure 32(iii)) which facilitates microscopic 
observation and image-based assays (Figure 33). We found that when we 
overlaid pristine Parylene membrane on top of the pre-formed spheroids, the 
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spheroids dissociated (Figure 33) likely due to the relatively hydrophobic nature 
of parylene and incompatible chemical moieties present on the surface of 
parylene membrane. We improved the surface by conjugating galactose 
moieties onto parylene surface to improve hepatocytes spheroids formation via 
galactose- asialoglycoprotein receptor interactions [206]. We found that the 
spheroids dissociated less but the filapodia-like structures were observed 
surrounding the spheroids. We postulate that this might due to the relatively stiff 
surface sensed by the cells since rigid surface has shown to promote cell-
substrates interactions through focal adhesions and decrease the cell-cell 
interactions forces that is requires for spheroids formation [137, 168]. We 
created a soft interface by conjugating PEG on parylene membrane, followed 
by galactose moieties. We found that hepatocytes spheroids maintained their 
morphology and cortical F-actin distribution when overlaid by PEG-AHG 
modified parylene membrane. 
We also improved the bottom galactose membrane by replacing the 
(poly)acrylic acid) layer with poly(ethylene glycol). Poly(acrylic acid) was 
previously conjugated onto PET film via UV-induced crosslinking [79, 174]. 
Such process is random and difficult to create a uniform layer over the coated 
surface. In our current approach, poly(ethylene glycol) with specific molecular 
weight was conjugated directly onto glass coverslip. AFM measurement shows 
that the surface of PEG-modified glass is indeed more uniform that the PAA-
modified PET. This might contribute to the reduced deviation in spheroids 
formation efficiency as shown in Figure 2D. Interestingly, we also found that 
the hepatocyte spheroids formed more rapidly when seeded on PEG-modified 
glass than PAA-modified PET. This might due to smoother surface on Glass-
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PEG as rough surface tends to increase cell adhesiveness [207] which might 
delay the hepatocytes migration to form spheroids. The hepatocyte migration 
on Glass-PEG-AHG was significantly faster than those on PET-PAA-AHG. 
More importantly, from drug testing point of view, earlier spheroids formation 
enabled drug testing to be performed on earlier time point, thereby minimizes 
valuable downtime and allows researcher to take advantage of the high CYP 
activity during the first few days of culture. More rapid formation of spheroids 
also allows perfusion culture to be initiated earlier. We subsequently show that 
immediate perfusion-initiation has significant positive impact on CYPs gene 
expression.   
Spheroids has certain advantages over collagen sandwich in terms of 
better polarity maintenance, higher urea secretion, and higher CYP1A2 activity, 
but with lower albumin synthesis. We found that perfusion culture enhance 
hepatocytes polarity maintenance and urea secretion further.  CYP1A2 activity 
was maintained at the same level as static culture spheroids, indicating 
spheroids configuration plays important role in maintaining CYP1A2 activity. 
CYP2B1/2 activity was comparable between collagen sandwich and spheroids, 
but the use of perfusion culture significantly enhances CYP2B1/2 function. 
More significantly, SCS-P showed almost 3 folds higher activity for CYP3A2, 
an enzyme orthologous to human CYP3A4 that is responsible for metabolism 
of two-thirds of all marketed drugs [198]. Taken altogether, collagen sandwich, 
SCS and SCS-P each have their strengths and weaknesses in maintaining 
different aspect of hepatocytes differentiated function. CYPs activity and 
transporter localization to apical surface are crucial in drug testing applications 




We have developed a perfusion-cultured sandwich-constrained 
hepatocyte culture model utilizing an improved spheroids formation bottom 
film and microfabricated parylene C porous membrane on top. Hepatocytes 
form and maintain spheroid morphology despite being trapped between 
membranes. The trapping mechanism allows hepatocyte spheroids to be 
subjected to perfusion flow without suffering from variable cell count which 
plagues drug testing assays. We found that the combination of perfusion culture 
and sandwich-constrained spheroid assembly exhibit enhanced attributes such 
as CYP1A2, CYP2B2, CYP3A2 activity and transporter localization to apical 
domain than static collagen sandwich culture and static spheroids culture, and 





7 Conclusion and future work 
We have developed a robust and high-throughput in vitro drug testing 
platform utilizing perfusion-cultured hepatocytes spheroids. Drawing insight 
from process design engineering, we started our work with a design that 
specifically cater to early stage drug screening development, ie. It must be 
robust and high throughput. After verifying our design, we proceeded to fine 
tune the materials and chemical modifications to enhance hepatocytes 
differentiated functions in vitro. Our final design consisting of a sandwich-
constrained spheroids construct that is subjectable to perfusion culture. The 
hepatocyte spheroid construct consists of a robust, elastic parylene C top 
membrane and polyethylene glycol/galactose-modified bottom surface. We 
used fixed molecular weight polyethylene glycol in modifying the bottom 
surface, giving a more uniform coverage and topography which induces 
hepatocytes spheroids formation earlier and with less deviation. Parylene C was 
picked as the top membrane given its elastic and flexible properties, which 
provides us with a robust material that can be scaled up or down with decent 
production efficiency.  It is also machinable and chemically modifiable, 
allowing us to customize the porosity and materials surface properties that are 
best suited to hepatocytes differentiated function maintenance. The top 
membrane serves 2 important purposes: first, it is a mechanical trap that 
stabilizes hepatocytes spheroids size and cell counts, which are the major factors 
that contribute to variability in using hepatocytes spheroids for drug testing; 
second, it also serves as a barrier to shear stress in perfusion flow. We found 
that perfusion flow further enhances hepatocytes spheroids function, possiblly 
due to enhanced mass transfer that is problematic in multicellular structures of 
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spheroids. Taking drug testing applications into consideration, all bioreactor 
designs adhere to standard commercial well-plate platform that allows 
integration with existing robotic liquid handler, thereby enabling high 
throughput drug testing.  
7.1 Developing a microfluidic bioreactor for more controlled perfusion 
environment 
In our current study, we have optimized the sandwich-constrained 
spheroids configurations but not the perfusion bioreactor. The perfusion 
bioreactors we were using were designed in macroscale dimension, with flow 
channel located a few millimetres above the cell surface (Figure 47), which is 
in multitude orders of magnitude compared to hepatocytes cell height of 20µm 
and typical endothelial cell barrier of 5µm.  
 
Figure 47. Fluid channel height gap in existing bioreactor 
 
The significant height gap between the hepatocytes cell surface and the 
perfusion flow results in a static culture-like diffusion driven mass exchange 
instead of perfusion flow convective driven mass exchange which is more 
effective. In fact, fluid flow modelling conducted on the bioreactor shows that 
the fluid flow velocity is close to 0m/s at the bottom of the well where the cells 





Figure 48. Computational fluid flow modeling for flow velocity in RoboTox. 
Reprinted from [1], Copyright 2014, with permission from Elsevier. 
 
To provide more effective mass exchange to the sandwich-constrained 
spheroids culture, it is crucial to bring the fluid flow channel as close to the cell 
surface as possible. This requires more precise fabrication process for the 
bioreactors. Microfluidics platforms fabricated using MEMS technology has 
shown to be able to fabricate microfluidics chips and bioreactors in the scale of 
micrometres. Thus we plan to replace the existing bioreactor with microfluidics 
platform for sandwich-constrained spheroids culture. 
A preliminary design of such bioreactor can be seen in Figure 49. The 
fluid flow channel is less than 500µm from membrane surface in this design.  
 




Our preliminary data shows that rat hepatocytes are able to survive and 
maintain their spheroid morphology for up to 24 days when cultured as 
sandwich-constrained spheroids in the microfluidic platform (Figure 50 and 
Figure 51). A more thorough study of the hepatocytes differentiated function, 
especially metabolism functions in this system over the long term is required.  
 
Figure 50. Light microscope pictures of sandwich constrained spheroids in 
microfluidics platform up to 24 days of culture. 
 
 
Figure 51. Live and dead staining of sandwich constrained spheroids in 
microfluidics platform after 24 days of culture. 
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7.2 Long term drug studies 
The significant advantage of perfusion-cultured sandwich-constrained 
spheroids is that it is able to maintain hepatocytes metabolism functions over a 
long period and at the same time deliver constant dose of drugs from reservoir, 
thus making it possible to conduct long drug term test such as slow metabolites 
discovery and chronic toxicity. 
Drug metabolism data is extremely important in drug development 
process, as it directly impact the disposition, safety and efficacy of the drugs. 
Freshly isolated primary hepatocytes are the best in vitro cell source for 
generating complete metabolite profiles as they offer the most complete drug 
metabolizing enzymes, including phase I and phase II enzymes, as well as 
maintaining the proper uptake and efflux capabilities. However, freshly isolated 
hepatocytes rapidly lose their differentiated functions, making it inadequate to 
generate metabolite profile of compounds that are metabolized slowly and/or 
extensively by liver[208]. It has been shown that longer term hepatocytes 
cultures are able to pick up additional metabolites from Linezolid[209], 
Ziprasidone [209], Diclofenac[210] etc. when compared to short term 
suspension culture. It will be interesting to subject our system to detect slow 
generating metabolites and metabolites that go through several transformation.  
Another potential application for perfusion-cultured sandwich 
constrained spheroids is to investigate chronic drug-induced hepatotoxicity. 
Drug-induced liver injury is still one of the main causes for drug attrition [211]. 
Many mechanisms contribute to drug-induced liver injury, whether directly by 
the parent compound or after bioactivation. However, only a few compounds 
induce hepatotoxicity within a few days. In most cases, liver injury is related to 
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long term treatments [212], thus there is a need for chronic toxicity testing 
where liver cells are exposed to repeated exposure of low dose over a long 
period[213]. To be able to do so, the hepatocytes cell culture model must be 
able to show long term viability and maintain functional drug-metabolizing 
activities [214]. Our perfusion-cultured sandwich constrained hepatocytes 
spheroids model has demonstrated both qualities and it will be of intense interest 
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9.1 Long term functional maintenance of hepatocytes in RoboTox 
Urea production of primary hepatocytes culture in RoboTox was 
significantly higher (140-200 μg/million cells/day) than urea production of 
hepatocytes in collagen sandwich and Si3N4 sandwich in static culture (<50 
μg/million cells/day, Figure 52). The urea production of RoboTox-cultured 
hepatocytes at day 14 was maintained at a level similar to earlier culture days 
(day 4 – day 8), albeit a slight drop was observed on days 10 and 12. In 
comparison, the urea production level of hepatocytes cultured in collagen 
sandwich and Si3N4 sandwich dropped irreversibly from day 10 onwards.  
 
 
Figure 52. Urea production of hepatocytes cultured in various configurations. 
 : collagen sandwich,  : Si3N4 sandwich,  : RoboTox. Data plotted 
represent the mean ± s.e.m of 3 independent experiments. *: p < 0.05. 
Reprinted from [1], Copyright 2014, with permission from Elsevier. 
 
Cytochrome p450 enzymes are involved in the phase I metabolism of 
drugs and were measured for the highly fluorescent 3-cyano-7-
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hydroxycoumarin (CHC) production upon incubation with metabolic substrate 
3-cyano-7-ethoxycoumarin (CEC) by de-alkylation of CEC [6, 215]. The CHC 
production of hepatocytes in RoboTox started at 35 μmol/million cells on days 
4 and 6 of culture and increased to 80 μmol/million cells from day 8 (Figure 53). 
The high level of CHC production was maintained at similar level till day 14. 
In comparison, the CHC productions from collagen sandwich and Si3N4 
sandwich in static culture were much lower (<20 μmol/million cells) and 
fluctuated throughout the 14 days culture period. CYP1A1 and CYP1A2 
enzymatic activities therefore were comparatively more stable and maintained 
at higher level in RoboTox. The F-actin staining, urea production and CHC 
conversion results show that hepatocytes cultured in RoboTox maintained 3D 
morphology and hepatocytes differentiated functions over a longer period. 
 
Figure 53. CHC production, an indication of p450 enzymatic activity, of 
hepatpcytes cultured in various configurations. .  : collagen sandwich,  : 
Si3N4 sandwich,  : RoboTox. Data plotted represent the mean ± s.e.m of 3 
independent experiments. *: p < 0.05. Reprinted from [1], Copyright 2014, 




9.2 Higher sensitivity and reduced variation in hepatotoxicity responses 
for hepatocytes cultured in RoboTox 
Different concentrations of APAP or diclofenac were added into the 
hepatocytes cultured in collagen sandwich, Si3N4 sandwich and RoboTox for 
48 hours and cell viability were evaluated by MTS assay. For APAP treated 
cultures, the viability of hepatocytes in RoboTox were lower than those in the 
collagen sandwich and Si3N4 sandwich in static conditions, especially at high 
concentrations (40 mM) of APAP (p<0.05) (Figure 54). For diclofenac treated 
cultures, the viability of hepatocytes in RoboTox were lower than those in the 
collagen sandwich and Si3N4 sandwich in static conditions for both 0.3 and 0.6 
mM (p<0.05) (Figure 54). These drug treatment results show that hepatocytes 
in RoboTox exhibit higher sensitivity towards drug-induced hepatotoxicity than 
hepatocytes in collagen sandwich and Si3N4 sandwich in static conditions when 
exposed to the same concentration of drugs. 
 
Figure 54. Higher drug sensitivity exhibited by RoboTox-cultured 
hepatocytes.  : collagen sandwich,  : Si3N4 sandwich,  : RoboTox. Data 
plotted represent the mean ± s.e.m of 3 independent experiments. *: p < 0.05. 
Reprinted from [1], Copyright 2014, with permission from Elsevier. 
 
The drug-induced hepatotoxicity response was compared using 
hepatocytes from different days of culture to investigate the variation of drug 
screening response throughout long term culture period. Hepatocytes cultured 
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in RoboTox were treated with APAP on day 4, day 8 or day 14 and cell viability 
was assessed. The cell viability of RoboTox-cultured hepatocytes after APAP 
treatment on different days was comparable (Figure 55) indicating consistent 
response to drug-induced hepatotoxicity throughout 14-day culture period. In 
comparison, cell viabilities in collagen sandwich and Si3N4  sandwich culture 
varied when 40mM APAP was treated, indicating significant variation towards 
APAP-induced hepatotoxicity throughout the 2-week culture period.  
 
Figure 55. Reduced variation in 40mM APAP-induced hepatotoxicity 
response for RoboTox-cultured hepatocytes. .  : day 4,  : day 8,  : day 14. 
Data plotted represent the mean ± s.e.m of 3 independent experiments. *: p < 
0.05. Reprinted from [1], Copyright 2014, with permission from Elsevier. 
 
9.3 Configuration of robotic liquid handler for IC50 testing on RoboTox 
platform 
9.3.1 Serial Dilution of Drugs using Robotic Liquid Handler  
Table 11. Setups required for serial dilution of drugs using robotic liquid handler 
 Plates Lid(Y/N) Location 
A Deep well drug dilution plate Y Hotel 
B Tip box (first row only) Y Hotel 
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C Tip box (except first row) Y Hotel 
D Culture medium reservoir N JANUS 
 
1. Move (A) from Hotel to JANUS position 1 
2. Move (B) from Hotel to JANUS position 2 
3. Move (C) from Hotel to JANUS position 3 
4. Delid (A) 
5. Delid (B) 
6. Delid (C) 
7. Transfer (C) from position 3 to tipload  
8. Get tips (C)  
9. Transfer medium from (D) to (A) 
10. Drop tips (C) 
11. Transfer (C) from tipload to position 3  
12. Transfer (B) from position 2 to tipload 
13. Get tips (B)  
14. Serial dilution (2x 167ul) from row A to row F (A) 
15. Drop tips (B) 
16. Transfer  (B) from tipload to position 2  
17. Lid (A) 
18. Move (A) from JANUS to Incubator 
19. Lid (B) 
20. Lid (C) 
21. Move (B) from JANUS to Hotel 
22. Move (C) from JANUS to hotel 
 
 
9.3.2 Adding Drugs to RoboTox-cultured Hepatocytes 
Table 12. Setups required for adding drugs onto RoboTox-cultured hepatocytes 
 Plates Lid(Y/N) Location 
A 96-well plate Y Hotel 
B Deep well drug dilution plate Y Incubator 
C Waste reservoir N JANUS 
S Sieve holding hepatocytes cells Y JANUS 
D Tip box (all tips) Y Hotel 
 
1. Move (A) from Hotel to JANUS position 1 
2. Move (D) from Hotel to JANUS position 2 
3. Move (B) from Incubator to JANUS position 3 
4. Delid (A) 
5. Delid (B) 
6. Delid (D) 
7. Move (D) from position 2 to tipload  
8. Get tips (D)  
9. Transfer 90ul medium from (B) to (A) 
10. (Manual) transfer (S) to (A) -> (SA) 
11. Transfer 150ul medium from (B) to (SA) 
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12. Lid (SA) 
13. Move (SA) from JANUS to Incubator 
14. Drop tips (D) 
15. (D) from tipload to position 2 
16. Lid (D) 
17. Lid (B) 
18. Move (D) from JANUS to Hotel  
19. Move (B) from JANUS to Hotel 
 
9.3.3 Adding MTS Solution to RoboTox-cultured Hepatocytes 
Table 13. Setups required for adding MTS solution onto RoboTox-cultured 
hepatocytes 
 Plates Lid(Y/N) Location 
A Tip box (all tips) Y Hotel 
C Waste reservoir N JANUS 
SG Plate with sieve  Y Incubator 
D MTS reservoir N JANUS 
E Sterile sponge N JANUS 
F 96-well plate Y Hotel 
 
1. Move (A) from Hotel to JANUS position 1 
2. Move (F) from Hotel to JANUS position 2 
3 Delid (A) 
4 Delid (F) 
5 Move (A) from position 1 to tipload  
6 Get tips (A) 
7 Transfer 90ul MTS from (D) to (F) 
8 Move (SG) from incubator to JANUS position 3 
9 Delid (SG) 
10 (Manual) Move sieve (S) from (G), dry on (E) then place on (F) 
-> (SF) 
11 Transfer 150ul MTS from (D) to (SF) 
12 Lid (SF) 
13 Move (SF) from JANUS to Incubator 
14 Start timer (1hours) 
15 Lid (G) 
16 Move (G) from JANUS to Hotel 
24 Drop tips (A) 
25 Move (A) from tipload to position 1 
26 Lid (A) 
27 Move (A) from JANUS to Hotel 
 
9.3.4 Reading MTS result for Collagen Sandwich-cultured Hepatocytes 
Table 14. Setups required for reading MTS results 
 Plates Lid(Y/N) Location 
A Tip box (all tips) Y Hotel 
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SB Plate with sieve Y Incubator 
D 96-well plate Y Hotel 
 
1. Timer up (1 hour) 
2. Move (A) from hotel to JANUS position 1 
3. Move (SB) from Incubator to JANUS position 2  
4. Delid (SB) 
5. (Manual) Remove sieve plate with cells from (SB) ->(B) 
6. Move (B) from JANUS to centrifuge 
7. Centrifuge speed (20g) time (2 min) 
8. Move (B) from centrifuge to JANUS position 2 
9. Move (D) from hotel to Barcode reader 
10. Delid (D) 
11. Move (D) from barcode reader to JANUS position 3 
12. Delid (A) 
13. Move (A) from position 1 to tipload  
14. Get tips (A)  
15. Transfer 90ul medium from (B) to (D) 
16. Move (D) to Tecan 
17. Tecan setting (Record absorbance at 490nm) 
18. Lid (D) 
19. Move (D) from Tecan to Hotel 
20. Drop tips (A) 
21. Move (A) from tipload to position 1  
22. Lid (A) 
23. Move (A) from JANUS to Hotel 
24. Lid (B) 
25. Move (B) from JANUS to Hotel 
 
9.4 Both PEG and galactose ligands modification on the top membrane 
are necessary to maintain hepatocytes spheroid morphology  
Hepatocytes spheroids formed on Glass-PEG-Gal were overlaid by 
parylene membrane with different modification. In the first configuration, 
parylene was modified with galactose only without the soft PEG hydrogel. In 
the second configuration, parylene was modified with soft PEG hydrogel but 
without galactose ligands. In the last configuration, parylene was modified with 
both PEG hydrogel and galactose ligands. We found that hepatocytes spheroids 
tends to spread in the first two configurations but not in the last configurations, 
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indicating that both PEG hydrogel and galactose ligands are essential for 
maintaining hepatocytes spheroids morphology.  
 
Figure 56. Hepatocytes spheroids overlaid by parylene membrane with 
different modification. 
 
 
 
